School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Richard Compans PhD

  • Administration
    Collabor Scientist
  • (404) 727-2015
  • rcompan@emory.edu
  • Emory University School of Medicine
    Microbiology and Immunology
    CNR 5005
Head shot of Richard Compans

Overview

Dr. Compans is a Professor in (and former Chair of) the Department of Microbiology and Immunology in the Emory University School of Medicine and is the Scientific Director of the Influenza Pathogenesis & Immunology Research Center (IPIRC). Before coming to Emory in 1992, he was a professor in the microbiology department of the University of Alabama at Birmingham. Dr. Compans received his Ph.D. from the Rockefeller University.

Research
Dr. Richard Compans is studying viral surface glycoproteins and their ability to elicit immune responses. These are the most important viral antigens in eliciting protective immunity. By assembling virus-like particles bearing these proteins, it is possible to create safe vaccines capable of inducing responses similar to those elicited by virus infection. Dr. Compans is exploring the possibility of using this approach to combat HIV, influenza, and viral hemorrhagic fevers, including Ebola, Lassa, and Marburg viruses.

A major focus of our group is to develop virus-like particle (VLP) based vaccine antigens which are effective in eliciting protective immune responses against viral infection. One project is focused on vaccines for HIV-1 prevention, with specific emphasis on inducing broadly reactive neutralizing antibody responses to primary HIV-1 isolates to prevent infection at mucosal surfaces. Other projects are focused on developing safe and effective vaccines to prevent pandemic influenza or viral hemorrhagic fever, employing VLPs containing the envelope glycoproteins of influenza, Marburg or Ebola virus on their surfaces.

Despite the success of vaccination against influenza, the virus has many subtypes, mutates rapidly and continues to elude complete or long-term protection, and therefore requires annual vaccination with an updated vaccine each year. In collaborative projects with Georgia Tech, new vaccine formulations and delivery methods such as vaccine-coated microneedle patches are being developed to provide an improved protective response, which would be of particular benefit to those at high risk of related complications. Vaccine delivery to the skin by microneedles is painless and offers other advantages such as eliminating potential risks due to use of hypodermic needles. Our recent studies demonstrate that microneedle vaccine patches are more effective at inducing protection against influenza virus than subcutaneous or intramuscular inoculation, as shown by more effective protection against lethal challenge and increased duration and breadth of immunity. We also observed that skin immunization with inactivated influenza virus using microneedles results in a local increase of cytokines important for recruitment of neutrophils, monocytes and dendritic cells at the site of immunization. All these cells can play a role in activating a strong immune response against the virus.

Academic Appointment

  • Professor, Dept. of Microbiology & Immunology, Emory University

Education

Degrees

  • PhD from The Rockefeller University
  • BA from Kalamazoo College

Research

Publications

  • Author Correction: Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge.
    Sci Rep Volume: 13 Page(s): 13705
    08/22/2023 Authors: Liu Y; Ye L; Lin F; Gomaa Y; Flyer D; Carrion R; Patterson JL; Prausnitz MR; Smith G; Glenn G
  • Taiwan's Response to Influenza: A Seroepidemiological Evaluation of Policies and Implications for Pandemic Preparedness.
    Int J Infect Dis Volume: 121 Page(s): 226 - 237
    08/01/2022 Authors: Ho P-I; Liu W; Li TZ-R; Chan T-C; Ku C-C; Lien Y-H; Shen Y-HD; Chen J-R; Yen M-Y; Tu Y-K
  • Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.
    Virology Volume: 562 Page(s): 197 - 208
    10/01/2021 Authors: Menne Z; Pliasas VC; Compans RW; Glover S; Kyriakis CS; Skountzou I
  • Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains.
    Proc Natl Acad Sci U S A Volume: 118
    05/11/2021 Authors: Dong C; Wang Y; Gonzalez GX; Ma Y; Song Y; Wang S; Kang S-M; Compans RW; Wang B-Z
  • Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent.
    Drug Deliv Transl Res Volume: 11 Page(s): 692 - 701
    04/01/2021 Authors: Kim YC; Lee JW; Esser ES; Kalluri H; Joyce JC; Compans RW; Skountzou I; Prausnitz MR
  • Are long-term influenza vaccines possible and how do we discover them?
    Expert Opin Drug Discov Volume: 16 Page(s): 213 - 216
    03/01/2021 Authors: Kim JK; Kang S-M; Compans RW; Wang B-Z
  • Nanoparticles for Rational Vaccine Design Preface
    Volume: 433 Page(s): V - VI
    01/01/2021 Authors: Gill HS; Compans RW
  • Cutaneous vaccination ameliorates Zika virus-induced neuro-ocular pathology via reduction of anti-ganglioside antibodies.
    Hum Vaccin Immunother Volume: 16 Page(s): 2072 - 2091
    09/01/2020 Authors: Beaver JT; Mills LK; Swieboda D; Lelutiu N; Esser ES; Antao OQ; Scountzou E; Williams DT; Papaioannou N; Littauer EQ
  • Influenza response planning for the centers of excellence for influenza research and surveillance: Science preparedness for enhancing global health security.
    Influenza Other Respir Viruses Volume: 14 Page(s): 444 - 451
    07/01/2020 Authors: Moore KA; Ostrowsky JT; Mehr AJ; Osterholm MT; CEIRS Pandemic Planning Committee
  • Intradermal Immunization of EBOV VLPs in Guinea Pigs Induces Broader Antibody Responses Against GP Than Intramuscular Injection.
    Front Microbiol Volume: 11 Page(s): 304
    01/01/2020 Authors: Liu Y; Wen Z; Carrion R; Nunneley J; Staples H; Ticer A; Patterson JL; Compans RW; Ye L; Yang C
  • cGAMP/Saponin Adjuvant Combination Improves Protective Response to Influenza Vaccination by Microneedle Patch in an Aged Mouse Model.
    Front Immunol Volume: 11 Page(s): 583251
    01/01/2020 Authors: Vassilieva EV; Li S; Korniychuk H; Taylor DM; Wang S; Prausnitz MR; Compans RW
  • [Extended delivery of vaccines to the skin improves immune responses].
    J Control Release Volume: 304 Page(s): 135 - 145
    06/28/2019 Authors: Joyce JC; Sella HE; Jost H; Mistilis MJ; Esser ES; Pradhan P; Toy R; Collins ML; Rota PA; Roy K
  • Co-Delivery of M2e Virus-Like Particles with Influenza Split Vaccine to the Skin Using Microneedles Enhances the Efficacy of Cross Protection.
    Pharmaceutics Volume: 11
    04/18/2019 Authors: Kim M-C; Kim K-H; Lee JW; Lee Y-N; Choi H-J; Jung Y-J; Kim Y-J; Compans RW; Prausnitz MR; Kang S-M
  • Combination of STING Pathway Agonist With Saponin Is an Effective Adjuvant in Immunosenescent Mice.
    Front Immunol Volume: 10 Page(s): 3006
    01/01/2019 Authors: Vassilieva EV; Taylor DW; Compans RW
  • Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge.
    J Infect Dis Volume: 218 Page(s): S545 - S552
    11/22/2018 Authors: Liu Y; Ye L; Lin F; Gomaa Y; Flyer D; Carrion R; Patterson JL; Prausnitz MR; Smith G; Glenn G
  • Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.
    Proc Natl Acad Sci U S A Volume: 115 Page(s): E7758 - E7767
    08/14/2018 Authors: Deng L; Chang TZ; Wang Y; Li S; Wang S; Matsuyama S; Yu G; Compans RW; Li J-D; Prausnitz MR
  • Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge.
    Sci Rep Volume: 8 Page(s): 11193
    07/25/2018 Authors: Liu Y; Ye L; Lin F; Gomaa Y; Flyer D; Carrion R; Patterson JL; Prausnitz MR; Smith G; Glenn G
  • Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.
    J Control Release Volume: 276 Page(s): 1 - 16
    04/28/2018 Authors: Littauer EQ; Mills LK; Brock N; Esser ES; Romanyuk A; Pulit-Penaloza JA; Vassilieva EV; Beaver JT; Antao O; Krammer F
  • NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
    mBio Volume: 9
    04/03/2018 Authors: Krammer F; Fouchier RAM; Eichelberger MC; Webby RJ; Shaw-Saliba K; Wan H; Wilson PC; Compans RW; Skountzou I; Monto AS
  • Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses.
    Nat Commun Volume: 9 Page(s): 359
    01/24/2018 Authors: Deng L; Mohan T; Chang TZ; Gonzalez GX; Wang Y; Kwon Y-M; Kang S-M; Compans RW; Champion JA; Wang B-Z
  • Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.
    Vaccines (Basel) Volume: 5
    12/19/2017 Authors: Gangadhara S; Kwon Y-M; Jeeva S; Quan F-S; Wang B; Moss B; Compans RW; Amara RR; Jabbar MA; Kang S-M
  • Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine.
    Sci Rep Volume: 7 Page(s): 17855
    12/19/2017 Authors: Vassilieva EV; Wang S; Li S; Prausnitz MR; Compans RW
  • H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation.
    PLoS Pathog Volume: 13 Page(s): e1006757
    11/01/2017 Authors: Littauer EQ; Esser ES; Antao OQ; Vassilieva EV; Compans RW; Skountzou I
  • The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial.
    Lancet Volume: 390 Page(s): 649 - 658
    08/12/2017 Authors: Rouphael NG; Paine M; Mosley R; Henry S; McAllister DV; Kalluri H; Pewin W; Frew PM; Yu T; Thornburg NJ
  • Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring.
    Sci Rep Volume: 7 Page(s): 5705
    07/18/2017 Authors: Esser ES; Pulit-Penaloza JA; Kalluri H; McAllister D; Vassilieva EV; Littauer EQ; Lelutiu N; Prausnitz MR; Compans RW; Skountzou I
  • Long-term stability of influenza vaccine in a dissolving microneedle patch.
    Drug Deliv Transl Res Volume: 7 Page(s): 195 - 205
    04/01/2017 Authors: Mistilis MJ; Joyce JC; Esser ES; Skountzou I; Compans RW; Bommarius AS; Prausnitz MR
  • Chimeric virus-like particles containing influenza HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against H3N2 viruses.
    Sci Rep Volume: 7 Page(s): 40226
    04/22/2009 Authors: Mohan T; Berman Z; Luo Y; Wang C; Wang S; Compans RW; Wang B-Z
  • Ebola Vaccination Using a DNA Vaccine Coated on PLGA-PLL/PGA Nanoparticles Administered Using a Microneedle Patch.
    Adv Healthc Mater Volume: 6
    01/01/2017 Authors: Yang H-W; Ye L; Guo XD; Yang C; Compans RW; Prausnitz MR
  • Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.
    Nanomedicine Volume: 13 Page(s): 253 - 262
    01/01/2017 Authors: Wang L; Chang TZ; He Y; Kim JR; Wang S; Mohan T; Berman Z; Tompkins SM; Tripp RA; Compans RW
  • "Cytoplasmic domain effects on exposure of co-receptor-binding sites of HIV-1 Env".
    Arch Virol Volume: 161 Page(s): 3011 - 3018
    11/01/2016 Authors: Vzorov AN; Compans RW
  • Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy.
    J Control Release Volume: 236 Page(s): 47 - 56
    08/28/2016 Authors: Esser ES; Romanyuk A; Vassilieva EV; Jacob J; Prausnitz MR; Compans RW; Skountzou I
  • Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses.
    J Control Release Volume: 233 Page(s): 208 - 219
    07/10/2016 Authors: Mohan T; Kim J; Berman Z; Wang S; Compans RW; Wang B-Z
  • Systemic dysregulation of cellular immune responses to H1N1 infection during pregnancy
    Volume: 196
    05/01/2016 Authors: Littauer EQ; Esser ES; Antao OQ; Williams DT; Compans RW; Skountzou I
  • Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle.
    Sci Rep Volume: 6 Page(s): 24897
    04/25/2016 Authors: Dye JM; Wu H; Hooper JW; Khurana S; Kuehne AI; Coyle EM; Ortiz RA; Fuentes S; Herbert AS; Golding H
  • Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
    Pharm Res Volume: 33 Page(s): 868 - 878
    04/01/2016 Authors: Chu LY; Ye L; Dong K; Compans RW; Yang C; Prausnitz MR
  • GPI-anchored CCL28 as a strong mucosal immunostimulator with influenza VLPs
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES Volume: 45 Page(s): 184 - 184
    04/01/2016 Authors: Mohan T; Compans RW; Wang B
  • Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines.
    Virology Volume: 489 Page(s): 141 - 150
    02/01/2016 Authors: Vzorov AN; Wang L; Chen J; Wang B-Z; Compans RW
  • [VLP vaccines and effects of HIV-1 Env protein modifications on their antigenic properties].
    Mol Biol (Mosk) Volume: 50 Page(s): 406 - 415
    01/01/2016 Authors: Vzorov AN; Compans RW
  • Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice.
    J Infect Dis Volume: 212 Suppl 2 Page(s): S398 - S403
    10/01/2015 Authors: Li W; Ye L; Carrion R; Mohan GS; Nunneley J; Staples H; Ticer A; Patterson JL; Compans RW; Yang C
  • Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts.
    Vaccine Volume: 33 Page(s): 4675 - 4682
    09/08/2015 Authors: Koutsonanos DG; Esser ES; McMaster SR; Kalluri P; Lee J-W; Prausnitz MR; Skountzou I; Denning TL; Kohlmeier JE; Compans RW
  • An amphipathic sequence in the cytoplasmic tail of HIV-1 Env alters cell tropism and modulates viral receptor specificity.
    Acta Virol Volume: 59 Page(s): 209 - 220
    09/01/2015 Authors: Vzorov AN; Yang C; Compans RW
  • Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
    Drug Deliv Transl Res Volume: 5 Page(s): 360 - 371
    08/01/2015 Authors: Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
  • Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor.
    Sci Rep Volume: 5 Page(s): 12321
    07/31/2015 Authors: Pulit-Penaloza JA; Sapkota B; Stein Esser E; Compans RW; Pollack BP; Skountzou I
  • Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs.
    Sci Rep Volume: 5 Page(s): 11856
    07/07/2015 Authors: Feng H; Zhang H; Deng J; Wang L; He Y; Wang S; Seyedtabaei R; Wang Q; Liu L; Galipeau J
  • Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses.
    Nanomedicine Volume: 11 Page(s): 1097 - 1107
    07/01/2015 Authors: Patel JM; Kim M-C; Vartabedian VF; Lee Y-N; He S; Song J-M; Choi H-J; Yamanaka S; Amaram N; Lukacher A
  • Topical application of an epidermal growth factor receptor kinase inhibitor enhances the response to influenza vaccination
    Volume: 135 Page(s): S8 - S8
    05/01/2015 Authors: Pollack BP; Skountzou I; Pulit-Penaloza JA; Compans RW; Sapkota B; Esser ES
  • Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity.
    J Virol Volume: 89 Page(s): 1205 - 1217
    01/15/2015 Authors: Mohan GS; Ye L; Li W; Monteiro A; Lin X; Sapkota B; Pollack BP; Compans RW; Yang C
  • Effect of Osmotic Pressure on the Stability of Whole Inactivated Influenza Vaccine for Coating on Microneedles.
    PLoS One Volume: 10 Page(s): e0134431
    01/01/2015 Authors: Choi H-J; Song J-M; Bondy BJ; Compans RW; Kang S-M; Prausnitz MR
  • Influenza Pathogenesis and Control - Volume II Preface
    Volume: 386 Page(s): V - VI
    01/01/2015 Authors: Oldstone MBA; Compans RW
  • Memory T cells generated by prior exposure to influenza cross react with the novel H7N9 influenza virus and confer protective heterosubtypic immunity.
    PLoS One Volume: 10 Page(s): e0115725
    01/01/2015 Authors: McMaster SR; Gabbard JD; Koutsonanos DG; Compans RW; Tripp RA; Tompkins SM; Kohlmeier JE
  • Skin immunization with influenza vaccines.
    Curr Top Microbiol Immunol Volume: 386 Page(s): 343 - 369
    01/01/2015 Authors: Skountzou I; Compans RW
  • Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.
    Antiviral Res Volume: 111 Page(s): 129 - 135
    11/01/2014 Authors: Lee S; Quan F-S; Kwon Y; Sakamoto K; Kang S-M; Compans RW; Moore ML
  • Influenza virus-specific neutralizing IgM antibodies persist for a lifetime.
    Clin Vaccine Immunol Volume: 21 Page(s): 1481 - 1489
    11/01/2014 Authors: Skountzou I; Satyabhama L; Stavropoulou A; Ashraf Z; Esser ES; Vassilieva E; Koutsonanos D; Compans R; Jacob J
  • A protective role of murine langerin cells in immune responses to cutaneous vaccination with microneedle patches.
    Sci Rep Volume: 4 Page(s): 6094
    08/18/2014 Authors: Pulit-Penaloza JA; Esser ES; Vassilieva EV; Lee JW; Taherbhai MT; Pollack BP; Prausnitz MR; Compans RW; Skountzou I
  • Distinct B-cell populations contribute to vaccine antigen-specific antibody production in a transgenic mouse model.
    Immunology Volume: 142 Page(s): 624 - 635
    08/01/2014 Authors: O E; Ko E-J; Kim M-C; Lee Y-T; Song J-M; Kwon Y-M; Compans RW; Kang S-M
  • Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.
    Mol Ther Volume: 22 Page(s): 1364 - 1374
    07/01/2014 Authors: Kim M-C; Lee Y-N; Ko E-J; Lee JS; Kwon Y-M; Hwang HS; Song J-M; Song B-M; Lee Y-J; Choi J-G
  • Emergence and evolution of avian H5N2 influenza viruses in chickens in Taiwan.
    J Virol Volume: 88 Page(s): 5677 - 5686
    05/01/2014 Authors: Lee C-CD; Zhu H; Huang P-Y; Peng L; Chang Y-C; Yip C-H; Li Y-T; Cheung C-L; Compans R; Yang C
  • Universal influenza vaccines, a dream to be realized soon.
    Viruses Volume: 6 Page(s): 1974 - 1991
    04/29/2014 Authors: Zhang H; Wang L; Compans RW; Wang B-Z
  • Cutaneous immunization: an evolving paradigm in influenza vaccines.
    Expert Opin Drug Deliv Volume: 11 Page(s): 615 - 627
    04/01/2014 Authors: Gill HS; Kang S-M; Quan F-S; Compans RW
  • Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity.
    J Control Release Volume: 178 Page(s): 1 - 7
    03/28/2014 Authors: Wang B-Z; Gill HS; He C; Ou C; Wang L; Wang Y-C; Feng H; Zhang H; Prausnitz MR; Compans RW
  • Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.
    Nanomedicine Volume: 10 Page(s): 473 - 482
    02/01/2014 Authors: Wang L; Hess A; Chang TZ; Wang Y-C; Champion JA; Compans RW; Wang B-Z
  • Influenza Pathogenesis and Control - Volume I Preface
    Volume: 385 Page(s): V - VI
    01/01/2014 Authors: Oldstone MBA; Compans RW
  • Protocatechuic acid, a novel active substance against avian influenza virus H9N2 infection.
    PLoS One Volume: 9 Page(s): e111004
    01/01/2014 Authors: Ou C; Shi N; Yang Q; Zhang Y; Wu Z; Wang B; Compans RW; He C
  • Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.
    J Control Release Volume: 172 Page(s): 579 - 588
    12/10/2013 Authors: Kim Y-C; Yoo D-G; Compans RW; Kang S-M; Prausnitz MR
  • Mucosal adjuvants for influenza virus-like particle vaccine.
    Viral Immunol Volume: 26 Page(s): 385 - 395
    12/01/2013 Authors: Quan F-S; Ko E-J; Kwon Y-M; Joo KH; Compans RW; Kang S-M
  • Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine.
    Adv Healthc Mater Volume: 2 Page(s): 1401 - 1410
    10/01/2013 Authors: Pearton M; Pirri D; Kang S-M; Compans RW; Birchall JC
  • Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection.
    Antiviral Res Volume: 99 Page(s): 328 - 335
    09/01/2013 Authors: Kim M-C; Lee J-S; Kwon Y-M; O E; Lee Y-J; Choi J-G; Wang B-Z; Compans RW; Kang S-M
  • Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
    Clin Vaccine Immunol Volume: 20 Page(s): 1433 - 1439
    09/01/2013 Authors: Quan F-S; Kim Y-C; Song J-M; Hwang HS; Compans RW; Prausnitz MR; Kang S-M
  • Gain-of-function experiments on H7N9.
    Science Volume: 341 Page(s): 612 - 613
    08/09/2013 Authors: Fouchier RAM; Kawaoka Y; Cardona C; Compans RW; Garca-Sastre A; Govorkova EA; Guan Y; Herfst S; Orenstein WA; Peiris JSM
  • Avian flu: Gain-of-function experiments on H7N9.
    Nature Volume: 500 Page(s): 150 - 151
    08/08/2013 Authors: Fouchier RAM; Kawaoka Y; Cardona C; Compans RW; Fouchier RAM; Garca-Sastre A; Govorkova EA; Guan Y; Herfst S; Kawaoka Y
  • Gain-of-Function Experiments on H7N9.
    Science
    08/07/2013 Authors: Fouchier RAM; Kawaoka Y; Cardona C; Compans RW; Garca-Sastre A; Govorkova EA; Guan Y; Herfst S; Orenstein WA; Peiris JSM
  • GPI-GM-CSF protein transferred onto H5 influenza VLPs remains stably expressed and functionally active
    Volume: 190
    05/01/2013 Authors: Patel J; He S; Amaram N; Yamanaka S; Vartabedian V; Radhakrishnan V; Song JM; Shashidharamurthy R; Compans R; Kang S-M
  • Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles.
    J Control Release Volume: 166 Page(s): 159 - 171
    03/10/2013 Authors: Choi H-J; Bondy BJ; Yoo D-G; Compans RW; Kang S-M; Prausnitz MR
  • Transmission studies resume for avian flu.
    Science Volume: 339 Page(s): 520 - 521
    02/01/2013 Authors: Fouchier RAM; Garca-Sastre A; Kawaoka Y; Barclay WS; Bouvier NM; Brown IH; Capua I; Chen H; Compans RW; Couch RB
  • Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus.
    Mol Ther Volume: 21 Page(s): 485 - 492
    02/01/2013 Authors: Kim M-C; Song J-M; O E; Kwon Y-M; Lee Y-J; Compans RW; Kang S-M
  • Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus.
    Mol Ther Volume: 21 Page(s): 485 - 492
    02/01/2013 Authors: Kim M-C; Song J-M; Eunju O; Kwon Y-M; Lee Y-J; Compans RW; Kang S-M
  • Targeting the skin for microneedle delivery of influenza vaccine.
    Adv Exp Med Biol Volume: 785 Page(s): 121 - 132
    01/01/2013 Authors: Koutsonanos DG; Compans RW; Skountzou I
  • Virus-like particles containing the tetrameric ectodomain of influenza matrix protein 2 and flagellin induce heterosubtypic protection in mice.
    Biomed Res Int Volume: 2013 Page(s): 686549
    01/01/2013 Authors: Wang L; Wang Y-C; Feng H; Ahmed T; Compans RW; Wang B-Z
  • Closely related influenza viruses induce contrasting respiratory tract immunopathology.
    PLoS One Volume: 8 Page(s): e76708
    01/01/2013 Authors: Le VL; Courtney CL; Steel J; Compans RW
  • Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.
    Virology Volume: 430 Page(s): 127 - 135
    09/01/2012 Authors: Quan F-S; Kim M-C; Lee B-J; Song J-M; Compans RW; Kang S-M
  • Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand.
    Clin Vaccine Immunol Volume: 19 Page(s): 1119 - 1125
    08/01/2012 Authors: Wang B-Z; Gill HS; Kang S-M; Wang L; Wang Y-C; Vassilieva EV; Compans RW
  • Virus-like particles as universal influenza vaccines.
    Expert Rev Vaccines Volume: 11 Page(s): 995 - 1007
    08/01/2012 Authors: Kang S-M; Kim M-C; Compans RW
  • DNA vaccination in the skin using microneedles improves protection against influenza.
    Mol Ther Volume: 20 Page(s): 1472 - 1480
    07/01/2012 Authors: Song J-M; Kim Y-C; O E; Compans RW; Prausnitz MR; Kang S-M
  • Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.
    Eur J Pharm Biopharm Volume: 81 Page(s): 239 - 247
    06/01/2012 Authors: Kim Y-C; Song J-M; Lipatov AS; Choi S-O; Lee JW; Donis RO; Compans RW; Kang S-M; Prausnitz MR
  • Salmonella flagellin enhances mucosal immunity of avian influenza vaccine in chickens.
    Vet Microbiol Volume: 157 Page(s): 69 - 77
    05/25/2012 Authors: Chaung H-C; Cheng L-T; Hung L-H; Tsai P-C; Skountzou I; Wang B; Compans RW; Lien Y-Y
  • Harnessing Sendai virus to induce mucosal immunity
    Volume: 188
    05/01/2012 Authors: Thuc-vy L; Garcin D; Compans R
  • Stability of influenza vaccine coated onto microneedles.
    Biomaterials Volume: 33 Page(s): 3756 - 3769
    05/01/2012 Authors: Choi H-J; Yoo D-G; Bondy BJ; Quan F-S; Compans RW; Kang S-M; Prausnitz MR
  • Influenza A virus pathogenesis: Identification of host factors that contribute to severe respiratory distress
    Volume: 188
    05/01/2012 Authors: Thuc-vy L; Steel J; Compans R
  • Adaptive immunity mediated by Natural Killer cells
    Volume: 188
    05/01/2012 Authors: Paust S; Flynn M; Wang B; Dougan S; Ploegh H; Telenti A; Compans R; von Andrian U
  • Stable incorporation of functionally active purified GPI-anchored immunostimulatory molecules on H5 influenza VLP surfaces by protein transfer
    Volume: 188
    05/01/2012 Authors: Patel J; Song JM; Shashidharamurthy R; Compans R; Kang S-M; Selvaraj P
  • H5N1. Ron Fouchier: in the eye of the storm.
    Science Volume: 335 Page(s): 388 - 389
    01/27/2012 Authors: Fouchier R
  • Pause on avian flu transmission research.
    Science Volume: 335 Page(s): 400 - 401
    01/27/2012 Authors: Fouchier RAM; Garca-Sastre A; Kawaoka Y; Barclay WS; Bouvier NM; Brown IH; Capua I; Chen H; Compans RW; Couch RB
  • Oral vaccination with inactivated influenza vaccine induces cross-protective immunity.
    Vaccine Volume: 30 Page(s): 180 - 188
    01/05/2012 Authors: Quan F-S; Compans RW; Kang S-M
  • Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10.
    PLoS One Volume: 7 Page(s): e31162
    01/01/2012 Authors: Kao C-L; Chan T-C; Tsai C-H; Chu K-Y; Chuang S-F; Lee C-C; Li Z-RT; Wu K-W; Chang L-Y; Shen Y-H
  • Local response to microneedle-based influenza immunization in the skin.
    mBio Volume: 3 Page(s): e00012 - e00012
    01/01/2012 Authors: del Pilar Martin M; Weldon WC; Zarnitsyn VG; Koutsonanos DG; Akbari H; Skountzou I; Jacob J; Prausnitz MR; Compans RW
  • Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus.
    PLoS Pathog Volume: 8 Page(s): e1003065
    01/01/2012 Authors: Mohan GS; Li W; Ye L; Compans RW; Yang C
  • Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine.
    PLoS One Volume: 7 Page(s): e41501
    01/01/2012 Authors: Weldon WC; Zarnitsyn VG; Esser ES; Taherbhai MT; Koutsonanos DG; Vassilieva EV; Skountzou I; Prausnitz MR; Compans RW
  • Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection.
    Sci Rep Volume: 2 Page(s): 357
    01/01/2012 Authors: Koutsonanos DG; Vassilieva EV; Stavropoulou A; Zarnitsyn VG; Esser ES; Taherbhai MT; Prausnitz MR; Compans RW; Skountzou I
  • Protective effect of ginseng polysaccharides on influenza viral infection.
    PLoS One Volume: 7 Page(s): e33678
    01/01/2012 Authors: Yoo D-G; Kim M-C; Park M-K; Park K-M; Quan F-S; Song J-M; Wee JJ; Wang B-Z; Cho Y-K; Compans RW
  • Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza.
    Clin Vaccine Immunol Volume: 18 Page(s): 2010 - 2017
    12/01/2011 Authors: Hossain MJ; Bourgeois M; Quan F-S; Lipatov AS; Song J-M; Chen L-M; Compans RW; York I; Kang S-M; Donis RO
  • Novel vaccines against influenza viruses.
    Virus Res Volume: 162 Page(s): 31 - 38
    12/01/2011 Authors: Kang SM; Song JM; Compans RW
  • Effects of stabilization of the gp41 cytoplasmic domain on fusion activity and infectivity of SIVmac239.
    AIDS Res Hum Retroviruses Volume: 27 Page(s): 1213 - 1222
    11/01/2011 Authors: Vzorov AN; Compans RW
  • MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination.
    J Virol Volume: 85 Page(s): 11391 - 11400
    11/01/2011 Authors: Kang S-M; Yoo D-G; Kim M-C; Song J-M; Park M-K; O E; Quan F-S; Akira S; Compans RW
  • Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.
    J Infect Dis Volume: 204 Page(s): 987 - 995
    10/01/2011 Authors: Quan F-S; Kim Y; Lee S; Yi H; Kang S-M; Bozja J; Moore ML; Compans RW
  • Immunogenicity of low-pH treated whole viral influenza vaccine.
    Virology Volume: 417 Page(s): 196 - 202
    08/15/2011 Authors: Quan F-S; Li Z-N; Kim M-C; Yang D; Compans RW; Steinhauer DA; Kang S-M
  • Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination.
    J Infect Dis Volume: 204 Page(s): 582 - 591
    08/15/2011 Authors: Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Jacob J; Prausnitz MR; Compans RW; Skountzou I
  • Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity.
    J Proteome Res Volume: 10 Page(s): 3450 - 3459
    08/05/2011 Authors: Song J-M; Choi C-W; Kwon S-O; Compans RW; Kang S-M; Kim SI
  • Induction of influenza-specific mucosal immunity by an attenuated recombinant Sendai virus.
    PLoS One Volume: 6 Page(s): e18780
    04/18/2011 Authors: Le T-VL; Mironova E; Garcin D; Compans RW
  • Adjuvanting influenza virus-like particles with glycophosphatidylinosital-anchored immunostimulatory molecules by protein transfer to enhance antiviral immune responses
    JOURNAL OF IMMUNOLOGY Volume: 186
    04/01/2011 Authors: Patel J; Song JM; Shashidharamurthy R; Compans R; Kang S-M; Selvaraj P
  • Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.
    Clin Vaccine Immunol Volume: 18 Page(s): 647 - 654
    04/01/2011 Authors: Weldon WC; Martin MP; Zarnitsyn V; Wang B; Koutsonanos D; Skountzou I; Prausnitz MR; Compans RW
  • Programming the magnitude and persistence of antibody responses with innate immunity.
    Nature Volume: 470 Page(s): 543 - 547
    02/24/2011 Authors: Kasturi SP; Skountzou I; Albrecht RA; Koutsonanos D; Hua T; Nakaya HI; Ravindran R; Stewart S; Alam M; Kwissa M
  • Influenza virus-like particles containing M2 induce broadly cross protective immunity.
    PLoS One Volume: 6 Page(s): e14538
    01/18/2011 Authors: Song J-M; Wang B-Z; Park K-M; Van Rooijen N; Quan F-S; Kim M-C; Jin H-T; Pekosz A; Compans RW; Kang S-M
  • Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.
    J Exp Med Volume: 208 Page(s): 181 - 193
    01/17/2011 Authors: Wrammert J; Koutsonanos D; Li G-M; Edupuganti S; Sui J; Morrissey M; McCausland M; Skountzou I; Hornig M; Lipkin WI
  • Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus.
    Proc Natl Acad Sci U S A Volume: 108 Page(s): 757 - 761
    01/11/2011 Authors: Song J-M; Van Rooijen N; Bozja J; Compans RW; Kang S-M
  • Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.
    Pharm Res Volume: 28 Page(s): 135 - 144
    01/01/2011 Authors: Kim Y-C; Quan F-S; Compans RW; Kang S-M; Prausnitz MR
  • Enhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant.
    mBio Volume: 2 Page(s): e00328 - e00310
    01/01/2011 Authors: Vassilieva EV; Wang B-Z; Vzorov AN; Wang L; Wang Y-C; Bozja J; Xu R; Compans RW
  • Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.
    PLoS One Volume: 6 Page(s): e14813
    01/01/2011 Authors: Ye L; Wen Z; Dong K; Wang X; Bu Z; Zhang H; Compans RW; Yang C
  • Immune stimulation following microneedle delivery of influenza virus-like particle (VLP) vaccines to human skin
    Volume: 15 Page(s): 1111 - 1111
    12/01/2010 Authors: Pearton M; Kang S-M; Song J-M; Kim Y-C; Quan F-S; Ivory M; Prausnitz MR; Compans RW; Birchall JC
  • Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.
    Nat Immunol Volume: 11 Page(s): 1127 - 1135
    12/01/2010 Authors: Paust S; Gill HS; Wang B-Z; Flynn MP; Moseman EA; Senman B; Szczepanik M; Telenti A; Askenase PW; Compans RW
  • Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection.
    PLoS One Volume: 5 Page(s): e13972
    11/29/2010 Authors: Wang B-Z; Xu R; Quan F-S; Kang S-M; Wang L; Compans RW
  • Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.
    Antiviral Res Volume: 88 Page(s): 244 - 247
    11/01/2010 Authors: Song J-M; Kim Y-C; Barlow PG; Hossain MJ; Park K-M; Donis RO; Prausnitz MR; Compans RW; Kang S-M
  • Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
    J Control Release Volume: 147 Page(s): 326 - 332
    11/01/2010 Authors: Quan F-S; Kim Y-C; Compans RW; Prausnitz MR; Kang S-M
  • Enhancing immunogenicity of HIV virus-like particles (VLPs) by incorporation of membrane-anchored flagellin
    Volume: 26 Page(s): A132 - A132
    10/01/2010 Authors: Vassilieva E; Wang B; Bozja J; Compans RW
  • Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles.
    Virology Volume: 405 Page(s): 165 - 175
    09/15/2010 Authors: Song J-M; Hossain J; Yoo D-G; Lipatov AS; Davis CT; Quan F-S; Chen L-M; Hogan RJ; Donis RO; Compans RW
  • Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.
    Clin Vaccine Immunol Volume: 17 Page(s): 1381 - 1389
    09/01/2010 Authors: Song J-M; Kim Y-C; Lipatov AS; Pearton M; Davis CT; Yoo D-G; Park K-M; Chen L-M; Quan F-S; Birchall JC
  • Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin.
    PLoS One Volume: 5
    09/01/2010 Authors: Weldon WC; Wang B-Z; Martin MP; Koutsonanos DG; Skountzou I; Compans RW
  • Formulation of microneedles coated with influenza virus-like particle vaccine.
    AAPS PharmSciTech Volume: 11 Page(s): 1193 - 1201
    09/01/2010 Authors: Kim Y-C; Quan F-S; Compans RW; Kang S-M; Prausnitz MR
  • Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines.
    PLoS One Volume: 5 Page(s): e12410
    08/25/2010 Authors: Pearton M; Kang S-M; Song J-M; Anstey AV; Ivory M; Compans RW; Birchall JC
  • Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.
    Vaccine Volume: 28 Page(s): 6104 - 6113
    08/23/2010 Authors: Pearton M; Kang S-M; Song J-M; Kim Y-C; Quan F-S; Anstey A; Ivory M; Prausnitz MR; Compans RW; Birchall JC
  • Dissolving polymer microneedle patches for influenza vaccination.
    Nat Med Volume: 16 Page(s): 915 - 920
    08/01/2010 Authors: Sullivan SP; Koutsonanos DG; Del Pilar Martin M; Lee JW; Zarnitsyn V; Choi S-O; Murthy N; Compans RW; Skountzou I; Prausnitz MR
  • Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus.
    J Immunol Volume: 185 Page(s): 1642 - 1649
    08/01/2010 Authors: Skountzou I; Koutsonanos DG; Kim JH; Powers R; Satyabhama L; Masseoud F; Weldon WC; Martin MDP; Mittler RS; Compans R
  • Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.
    J Virol Volume: 84 Page(s): 7760 - 7769
    08/01/2010 Authors: Quan F-S; Kim Y-C; Vunnava A; Yoo D-G; Song J-M; Prausnitz MR; Compans RW; Kang S-M
  • Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine.
    Vaccine Volume: 28 Page(s): 4103 - 4112
    05/28/2010 Authors: Skountzou I; Martin MDP; Wang B; Ye L; Koutsonanos D; Weldon W; Jacob J; Compans RW
  • Adjuvanted influenza vaccine administered intradermally elicits robust long-term immune responses that confer protection from lethal challenge.
    PLoS One Volume: 5 Page(s): e10897
    05/28/2010 Authors: Martin MDP; Seth S; Koutsonanos DG; Jacob J; Compans RW; Skountzou I
  • Corrigendum to "Protection against lethal challenge by Ebola virus-like particles produced in insect cells" [Virology 383 (2009) 12-21].
    Virology Volume: 399 Page(s): 186
    03/30/2010 Authors: Sun Y; Carrion R; Ye L; Wen Z; Ro Y-T; Brasky K; Ticer AE; Schwegler EE; Patterson JL; Compans RW
  • Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
    J Control Release Volume: 142 Page(s): 187 - 195
    03/03/2010 Authors: Kim Y-C; Quan F-S; Compans RW; Kang S-M; Prausnitz MR
  • Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice.
    PLoS One Volume: 5 Page(s): e9161
    02/11/2010 Authors: Quan F-S; Vunnava A; Compans RW; Kang S-M
  • Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.
    J Infect Dis Volume: 201 Page(s): 190 - 198
    01/15/2010 Authors: Kim Y-C; Quan F-S; Yoo D-G; Compans RW; Kang S-M; Prausnitz MR
  • Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles.
    Procedia Vaccinol Volume: 2 Page(s): 15 - 19
    01/01/2010 Authors: Kim Y-C; Quan F-S; Song J-M; Vunnava A; Yoo D-G; Park K-M; Compans RW; Kang S-M; Prausnitz MR
  • Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses.
    J Biomed Biotechnol Volume: 2010 Page(s): 497219
    01/01/2010 Authors: Ye L; Wen Z; Dong K; Pan L; Bu Z; Compans RW; Zhang H; Yang C
  • Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.
    Antiviral Res Volume: 84 Page(s): 215 - 224
    12/01/2009 Authors: Wen Z; Ye L; Gao Y; Pan L; Dong K; Bu Z; Compans RW; Yang C
  • Improved influenza vaccination in the skin using vaccine coated microneedles.
    Vaccine Volume: 27 Page(s): 6932 - 6938
    11/16/2009 Authors: Kim Y-C; Quan F-S; Yoo D-G; Compans RW; Kang S-M; Prausnitz MR
  • Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
    PLoS One Volume: 4 Page(s): e7152
    09/25/2009 Authors: Quan F-S; Kim Y-C; Yoo D-G; Compans RW; Prausnitz MR; Kang S-M
  • Original antigenic sin responses to influenza viruses.
    J Immunol Volume: 183 Page(s): 3294 - 3301
    09/01/2009 Authors: Kim JH; Skountzou I; Compans R; Jacob J
  • Influenza vaccines based on virus-like particles.
    Virus Res Volume: 143 Page(s): 140 - 146
    08/01/2009 Authors: Kang S-M; Song J-M; Quan F-S; Compans RW
  • Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge.
    Proc Natl Acad Sci U S A Volume: 106 Page(s): 7968 - 7973
    05/12/2009 Authors: Zhu Q; Zarnitsyn VG; Ye L; Wen Z; Gao Y; Pan L; Skountzou I; Gill HS; Prausnitz MR; Yang C
  • Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination.
    J Virol Volume: 83 Page(s): 4489 - 4497
    05/01/2009 Authors: Quan FS; Yoo D-G; Song J-M; Clements JD; Compans RW; Kang S-M
  • Host responses from innate to adaptive immunity after vaccination: molecular and cellular events.
    Mol Cells Volume: 27 Page(s): 5 - 14
    01/31/2009 Authors: Kang S-M; Compans RW
  • Protection against lethal challenge by Ebola virus-like particles produced in insect cells.
    Virology Volume: 383 Page(s): 12 - 21
    01/05/2009 Authors: Sun Y; Carrion R; Ye L; Wen Z; Ro Y-T; Brasky K; Ticer AE; Schwegler EE; Patterson JL; Compans RW
  • Influenza virus-like particles as pandemic vaccines.
    Curr Top Microbiol Immunol Volume: 333 Page(s): 269 - 289
    01/01/2009 Authors: Kang SM; Pushko P; Bright RA; Smith G; Compans RW
  • Induction of long-term protective immune responses by influenza H5N1 virus-like particles.
    PLoS One Volume: 4 Page(s): e4667
    01/01/2009 Authors: Kang S-M; Yoo D-G; Lipatov AS; Song J-M; Davis CT; Quan F-S; Chen L-M; Donis RO; Compans RW
  • Vaccines for pandemic influenza. Preface.
    Curr Top Microbiol Immunol Volume: 333 Page(s): v - viii
    01/01/2009 Authors: Compans RW; Orenstein WA
  • Transdermal influenza immunization with vaccine-coated microneedle arrays.
    PLoS One Volume: 4 Page(s): e4773
    01/01/2009 Authors: Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I
  • Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.
    J Virol Volume: 82 Page(s): 11813 - 11823
    12/01/2008 Authors: Wang B-Z; Quan F-S; Kang S-M; Bozja J; Skountzou I; Compans RW
  • A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs.
    Vaccine Volume: 26 Page(s): 3352 - 3361
    06/19/2008 Authors: Quan FS; Steinhauer D; Huang C; Ross TM; Compans RW; Kang S-M
  • Protection against filovirus infection: virus-like particle vaccines.
    Expert Rev Vaccines Volume: 7 Page(s): 333 - 344
    04/01/2008 Authors: Yang C; Ye L; Compans RW
  • Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responses.
    Vaccine Volume: 26 Page(s): 1541 - 1551
    03/17/2008 Authors: Raska M; Moldoveanu Z; Novak J; Hel Z; Novak L; Bozja J; Compans RW; Yang C; Mestecky J
  • Induction of heterosubtypic immunity to influenza virus by intranasal immunization.
    J Virol Volume: 82 Page(s): 1350 - 1359
    02/01/2008 Authors: Quan F-S; Compans RW; Nguyen HH; Kang S-M
  • Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection.
    Retrovirology Volume: 4 Page(s): 94
    12/14/2007 Authors: Vzorov AN; Weidmann A; Kozyr NL; Khaoustov V; Yoffe B; Compans RW
  • Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.
    J Virol Volume: 81 Page(s): 10869 - 10878
    10/01/2007 Authors: Wang B-Z; Liu W; Kang S-M; Alam M; Huang C; Ye L; Sun Y; Li Y; Kothe DL; Pushko P
  • Human immunodeficiency virus-like particles activate multiple types of immune cells.
    Virology Volume: 362 Page(s): 331 - 341
    06/05/2007 Authors: Sailaja G; Skountzou I; Quan F-S; Compans RW; Kang S-M
  • Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins.
    Vaccine Volume: 25 Page(s): 3841 - 3850
    05/10/2007 Authors: Quan F-S; Sailaja G; Skountzou I; Huang C; Vzorov A; Compans RW; Kang S-M
  • Fusogenic variants of a noncytopathic paramyxovirus.
    J Virol Volume: 81 Page(s): 4286 - 4297
    04/01/2007 Authors: Seth S; Skountzou I; Gernert KM; Compans RW
  • Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.
    J Virol Volume: 81 Page(s): 3514 - 3524
    04/01/2007 Authors: Quan F-S; Huang C; Compans RW; Kang S-M
  • Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles.
    J Virol Volume: 81 Page(s): 1083 - 1094
    02/01/2007 Authors: Skountzou I; Quan F-S; Gangadhara S; Ye L; Vzorov A; Selvaraj P; Jacob J; Compans RW; Kang S-M
  • Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.
    Vaccine Volume: 25 Page(s): 272 - 282
    01/04/2007 Authors: Quan FS; Compans RW; Cho Y-K; Kang S-M
  • Parameters of inhibition of HIV-1 infection by small anionic microbicides.
    Antiviral Res Volume: 73 Page(s): 60 - 68
    01/01/2007 Authors: Vzorov AN; Bozja J; Dixon DW; Marzilli LG; Compans RW
  • Transcutaneous immunization with inactivated influenza virus induces protective immune responses.
    Vaccine Volume: 24 Page(s): 6110 - 6119
    08/28/2006 Authors: Skountzou I; Quan F-S; Jacob J; Compans RW; Kang S-M
  • Nonpeptide inhibitors of measles virus entry.
    J Med Chem Volume: 49 Page(s): 5080 - 5092
    08/24/2006 Authors: Sun A; Prussia A; Zhan W; Murray EE; Doyle J; Cheng L-T; Yoon J-J; Radchenko EV; Palyulin VA; Compans RW
  • Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.
    Virology Volume: 352 Page(s): 74 - 85
    08/15/2006 Authors: Ye L; Sun Y; Lin J; Bu Z; Wu Q; Jiang S; Steinhauer DA; Compans RW; Yang C
  • Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies.
    Virology Volume: 351 Page(s): 260 - 270
    08/01/2006 Authors: Ye L; Lin J; Sun Y; Bennouna S; Lo M; Wu Q; Bu Z; Pulendran B; Compans RW; Yang C
  • Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    J Virol Volume: 80 Page(s): 6106 - 6114
    06/01/2006 Authors: Li M; Li Z-N; Yao Q; Yang C; Steinhauer DA; Compans RW
  • Rational design of measles virus entry inhibitors and mechanisms of viral resistance
    Volume: 231
    03/26/2006 Authors: Prussia AJ; Plemper RK; Sun A; Doyle J; White LK; Cheng L-T; Liotta DC; Snyder JP; Compans RW
  • Two domains that control prefusion stability and transport competence of the measles virus fusion protein.
    J Virol Volume: 80 Page(s): 1524 - 1536
    02/01/2006 Authors: Doyle J; Prussia A; White LK; Sun A; Liotta DC; Snyder JP; Compans RW; Plemper RK
  • Design of a small-molecule entry inhibitor with activity against primary measles virus strains.
    Antimicrob Agents Chemother Volume: 49 Page(s): 3755 - 3761
    09/01/2005 Authors: Plemper RK; Doyle J; Sun A; Prussia A; Cheng L-T; Rota PA; Liotta DC; Snyder JP; Compans RW
  • Sulfonated naphthyl porphyrins as agents against HIV-1.
    J Inorg Biochem Volume: 99 Page(s): 813 - 821
    03/01/2005 Authors: Dixon DW; Gill AF; Giribabu L; Vzorov AN; Alam AB; Compans RW
  • Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity.
    Virology Volume: 332 Page(s): 89 - 101
    02/05/2005 Authors: Vzorov AN; Gernert KM; Compans RW
  • Prevention of HIV-1 infection by platinum triazines.
    Antiviral Res Volume: 65 Page(s): 57 - 67
    02/01/2005 Authors: Vzorov AN; Bhattacharyya D; Marzilli LG; Compans RW
  • Atypical fusion peptide of Nelson Bay virus fusion-associated small transmembrane protein.
    J Virol Volume: 79 Page(s): 1853 - 1860
    02/01/2005 Authors: Cheng LT; Plemper RK; Compans RW
  • Mucosal immunization of CD4+ T cell-deficient mice with an inactivated virus induces IgG and IgA responses in serum and mucosal secretions.
    Virology Volume: 331 Page(s): 387 - 395
    01/20/2005 Authors: Sha Z; Kang S-M; Compans RW
  • Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies.
    Virology Volume: 331 Page(s): 20 - 32
    01/05/2005 Authors: Kang S-M; Quan FS; Huang C; Guo L; Ye L; Yang C; Compans RW
  • Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain.
    J Virol Volume: 78 Page(s): 13409 - 13419
    12/01/2004 Authors: Ye L; Bu Z; Vzorov A; Taylor D; Compans RW; Yang C
  • Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain.
    Virology Volume: 328 Page(s): 62 - 73
    10/10/2004 Authors: Bu Z; Ye L; Vzorov A; Taylor D; Compans RW; Yang C
  • Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens.
    J Virol Volume: 78 Page(s): 9624 - 9632
    09/01/2004 Authors: Kang S-M; Guo L; Yao Q; Skountzou I; Compans RW
  • Inhibition of the measles virus cell entry: Fusion blockade.
    Volume: 228 Page(s): U968 - U968
    08/22/2004 Authors: Sun AM; Plemper RK; Erlandson KJ; Lakdawala A; Prussia A; Akisener E; Yalcin I; Yildliz I; Temiz-Arpaci O; Tekiner B
  • Mutations in multiple domains activate paramyxovirus F protein-induced fusion.
    J Virol Volume: 78 Page(s): 8513 - 8523
    08/01/2004 Authors: Seth S; Goodman AL; Compans RW
  • Influenza virus inhibits ENaC and lung fluid clearance.
    Am J Physiol Lung Cell Mol Physiol Volume: 287 Page(s): L366 - L373
    08/01/2004 Authors: Chen X-J; Seth S; Yue G; Kamat P; Compans RW; Guidot D; Brown LA; Eaton DC; Jain L
  • Lentiviral vectors pseudotyped with envelope glycoproteins derived from human parainfluenza virus type 3
    Volume: 9 Page(s): S278 - S278
    05/01/2004 Authors: Jung C; Grzybowski BN; Tong SX; Cheng LT; Compans RW; Le Doux JM
  • A target site for template-based design of measles virus entry inhibitors.
    Proc Natl Acad Sci U S A Volume: 101 Page(s): 5628 - 5633
    04/13/2004 Authors: Plemper RK; Erlandson KJ; Lakdawala AS; Sun A; Prussia A; Boonsombat J; Aki-Sener E; Yalcin I; Yildiz I; Temiz-Arpaci O
  • Lentiviral vectors pseudotyped with envelope glycoproteins derived from human parainfluenza virus type 3.
    Biotechnol Prog Volume: 20 Page(s): 1810 - 1816
    01/01/2004 Authors: Jung C; Grzybowski BN; Tong S; Cheng L; Compans RW; Le Doux JM
  • Enhanced immunogenicity of SIV Gag DNA vaccines encoding chimeric proteins containing a C-terminal segment of Listeriolysin O.
    Virus Res Volume: 97 Page(s): 7 - 16
    11/01/2003 Authors: Ye L; Bu Z; Skeen MJ; Ziegler HK; Compans RW; Yang C
  • Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B.
    J Virol Volume: 77 Page(s): 9823 - 9830
    09/01/2003 Authors: Kang S-M; Yao Q; Guo L; Compans RW
  • Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles.
    Virology Volume: 313 Page(s): 502 - 513
    09/01/2003 Authors: Guo L; Lu X; Kang S-M; Chen C; Compans RW; Yao Q
  • Prevention of HIV-1 infection by phthalocyanines.
    Antiviral Res Volume: 59 Page(s): 99 - 109
    07/01/2003 Authors: Vzorov AN; Marzilli LG; Compans RW; Dixon DW
  • Structural features of paramyxovirus F protein required for fusion initiation.
    Biochemistry Volume: 42 Page(s): 6645 - 6655
    06/10/2003 Authors: Plemper RK; Lakdawala AS; Gernert KM; Snyder JP; Compans RW
  • Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process.
    J Virol Volume: 77 Page(s): 6520 - 6527
    06/01/2003 Authors: Seth S; Vincent A; Compans RW
  • Prevention of poxvirus infection by tetrapyrroles.
    BMC Infect Dis Volume: 3 Page(s): 9
    05/28/2003 Authors: Chen-Collins ARM; Dixon DW; Vzorov AN; Marzilli LG; Compans RW
  • Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins.
    Virology Volume: 309 Page(s): 272 - 281
    05/10/2003 Authors: Bu Z; Ye L; Compans RW; Yang C
  • Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O.
    AIDS Res Hum Retroviruses Volume: 19 Page(s): 409 - 420
    05/01/2003 Authors: Bu Z; Ye L; Skeen MJ; Ziegler HK; Compans RW; Yang C
  • Inhibition of influenza infection by glutathione.
    Free Radic Biol Med Volume: 34 Page(s): 928 - 936
    04/01/2003 Authors: Cai J; Chen Y; Seth S; Furukawa S; Compans RW; Jones DP
  • Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation.
    J Virol Volume: 77 Page(s): 4181 - 4190
    04/01/2003 Authors: Plemper RK; Compans RW
  • Sin Nombre virus glycoprotein trafficking.
    Virology Volume: 308 Page(s): 48 - 63
    03/30/2003 Authors: Spiropoulou CF; Goldsmith CS; Shoemaker TR; Peters CJ; Compans RW
  • Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus.
    J Virol Volume: 77 Page(s): 3615 - 3623
    03/01/2003 Authors: Kang S-M; Compans RW
  • Prevention of poxvirus infection by tetrapyrroles
    Volume: 57 Page(s): A72 - A72
    02/01/2003 Authors: Chen-Collins ARM; Dixon DW; Vzorov AN; Marzilli LG; Compans RW
  • Prevention of HIV-1 infection by phthalocyanines
    Volume: 57 Page(s): A49 - A49
    02/01/2003 Authors: Vzorov AN; Marzilli LG; Compans RW; Dixon DW
  • Virus-like particle and DNA-based candidate AIDS vaccines.
    Vaccine Volume: 21 Page(s): 638 - 643
    01/30/2003 Authors: Yao Q; Bu Z; Vzorov A; Yang C; Compans RW
  • Mutations in the cytoplasmic domain of a paramyxovirus fusion glycoprotein rescue syncytium formation and eliminate the hemagglutinin-neuraminidase protein requirement for membrane fusion.
    J Virol Volume: 77 Page(s): 167 - 178
    01/01/2003 Authors: Seth S; Vincent A; Compans RW
  • Inactivation of human immunodeficiency virus type 1 by porphyrins.
    Antimicrob Agents Chemother Volume: 46 Page(s): 3917 - 3925
    12/01/2002 Authors: Vzorov AN; Dixon DW; Trommel JS; Marzilli LG; Compans RW
  • Palmitoylation of the murine leukemia virus envelope protein is critical for lipid raft association and surface expression.
    J Virol Volume: 76 Page(s): 11845 - 11852
    12/01/2002 Authors: Li M; Yang C; Tong S; Weidmann A; Compans RW
  • Regulation of fusion activity by the cytoplasmic domain of a paramyxovirus F protein.
    Virology Volume: 301 Page(s): 322 - 333
    09/30/2002 Authors: Tong S; Li M; Vincent A; Compans RW; Fritsch E; Beier R; Klenk C; Ohuchi M; Klenk H-D
  • Newcastle disease virus oncolysate induces a significant and specific antimelanoma effect in a preclinical marine model system
    JOURNAL OF INVESTIGATIVE DERMATOLOGY Volume: 119 Page(s): 216 - 216
    07/01/2002 Authors: Campbell RM; Pham A; Compans R; Ansel JC; Armstrong CA
  • Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity.
    Vaccine Volume: 20 Page(s): 2537 - 2545
    06/07/2002 Authors: Yao Q; Vuong V; Li M; Compans RW
  • Influenza virus inhibits alveolar fluid clearance through inhibition of amiloride sensitive lung sodium channels
    PEDIATRIC RESEARCH Volume: 51 Page(s): 265A - 265A
    04/01/2002 Authors: Jain L; Yue G; Seth S; Chen XJ; Compans R; Eaton DC
  • Influenza virus inhibits epithelial sodium channels in alveolar type H cells
    FASEB JOURNAL Volume: 16 Page(s): A54 - A54
    03/20/2002 Authors: Yue G; Jain L; Seth S; Compans R; Chen XJ; Eaton DC
  • HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
    Virology Volume: 285 Page(s): 128 - 137
    06/20/2001 Authors: Yao Q; Compans RW; Chen C
  • An infectious clone of the West Nile flavivirus.
    Virology Volume: 281 Page(s): 294 - 304
    03/15/2001 Authors: Yamshchikov VF; Wengler G; Perelygin AA; Brinton MA; Compans RW
  • Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide.
    J Virol Volume: 75 Page(s): 2337 - 2344
    03/01/2001 Authors: Li M; Yang C; Compans RW
  • Three membrane-proximal amino acids in the human parainfluenza type 2 (HPIV 2) F protein are critical for fusogenic activity.
    Virology Volume: 280 Page(s): 52 - 61
    02/01/2001 Authors: Tong S; Yi F; Martin A; Yao Q; Li M; Compans RW
  • Hantavirus nucleocapsid protein is expressed as a membrane-associated protein in the perinuclear region.
    J Virol Volume: 75 Page(s): 1808 - 1815
    02/01/2001 Authors: Ravkov EV; Compans RW
  • In memoriam - Joseph Louis Melnick (1914-2001)
    ARCHIVES OF VIROLOGY Volume: 146 Page(s): 629 - 631
    01/01/2001 Authors: Compans RW; Mahy BWJ
  • The envelope glycoprotein of simian immunodeficiency virus contains an enterotoxin domain.
    Virology Volume: 277 Page(s): 250 - 261
    11/25/2000 Authors: Swaggerty CL; Frolov AA; McArthur MJ; Cox VW; Tong S; Compans RW; Ball JM
  • Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization.
    J Virol Volume: 74 Page(s): 8219 - 8225
    09/01/2000 Authors: Vzorov AN; Compans RW
  • Coreceptor-dependent inhibition of the cell fusion activity of simian immunodeficiency virus Env proteins.
    J Virol Volume: 74 Page(s): 6217 - 6222
    07/01/2000 Authors: Yang C; Yang Q; Compans RW
  • Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus.
    J Virol Volume: 74 Page(s): 4999 - 5005
    06/01/2000 Authors: Sha Z; Compans RW
  • Oligomerization, secretion, and biological function of an anchor-free parainfluenza virus type 2 (PI2) fusion protein.
    Virology Volume: 270 Page(s): 368 - 376
    05/10/2000 Authors: Tong S; Compans RW
  • Filamentous particle formation by human parainfluenza virus type 2.
    J Gen Virol Volume: 81 Page(s): 1305 - 1312
    05/01/2000 Authors: Yao Q; Compans RW
  • Introduction of CD4(+) T cell-independent immunoglobulin responses by inactivated influenza virus.
    FASEB JOURNAL Volume: 14 Page(s): A978 - A978
    04/20/2000 Authors: Sha Z; Compans RW
  • Production and characterization of simian--human immunodeficiency virus-like particles.
    AIDS Res Hum Retroviruses Volume: 16 Page(s): 227 - 236
    02/10/2000 Authors: Yao Q; Kuhlmann FM; Eller R; Compans RW; Chen C
  • Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway.
    J Virol Volume: 74 Page(s): 1513 - 1523
    02/01/2000 Authors: Balachandran S; Roberts PC; Kipperman T; Bhalla KN; Compans RW; Archer DR; Barber GN
  • Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees.
    Immunol Res Volume: 21 Page(s): 7 - 21
    01/01/2000 Authors: Lockey TD; Slobod KS; Caver TE; D'Costa S; Owens RJ; McClure HM; Compans RW; Hurwitz JL
  • Vesicular stomatitis virus G protein acquires pH-independent fusion activity during transport in a polarized endometrial cell line.
    J Virol Volume: 73 Page(s): 10447 - 10457
    12/01/1999 Authors: Roberts PC; Kipperman T; Compans RW
  • Induction of immune responses to SIV antigens by mucosally administered vaccines.
    AIDS Res Hum Retroviruses Volume: 15 Page(s): 1469 - 1476
    11/01/1999 Authors: Moldoveanu Z; Vzorov AN; Huang WQ; Mestecky J; Compans RW
  • Intracellular interaction of simian immunodeficiency virus Gag and Env proteins.
    J Virol Volume: 73 Page(s): 8138 - 8144
    10/01/1999 Authors: Vincent MJ; Melsen LR; Martin AS; Compans RW
  • Development of a rubella virus DNA vaccine.
    Vaccine Volume: 17 Page(s): 2104 - 2112
    04/09/1999 Authors: Pougatcheva SO; Abernathy ES; Vzorov AN; Compans RW; Frey TK
  • Enhancement of mucosal immune responses to the influenza virus HA protein by alternative approaches to DNA immunization.
    Immunobiology Volume: 200 Page(s): 21 - 30
    02/01/1999 Authors: Sha Z; Vincent MJ; Compans RW
  • Immunogenicity of full length and truncated SIV envelope proteins.
    Viral Immunol Volume: 12 Page(s): 205 - 215
    01/01/1999 Authors: Vzorov AN; Lea-Fox D; Compans RW
  • Alternative mechanisms of interaction between homotypic and heterotypic parainfluenza virus HN and F proteins.
    J Gen Virol Volume: 80 ( Pt 1) Page(s): 107 - 115
    01/01/1999 Authors: Tong S; Compans RW
  • Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus.
    Science Volume: 282 Page(s): 2079 - 2081
    12/11/1998 Authors: Cao W; Henry MD; Borrow P; Yamada H; Elder JH; Ravkov EV; Nichol ST; Compans RW; Campbell KP; Oldstone MB
  • A case of syncytial giant cell hepatitis with features of a paramyxoviral infection.
    Am J Gastroenterol Volume: 93 Page(s): 1931 - 1937
    10/01/1998 Authors: Fimmel CJ; Guo L; Compans RW; Brunt EM; Hickman S; Perrillo RR; Mason AL
  • Host cell dependence of viral morphology.
    Proc Natl Acad Sci U S A Volume: 95 Page(s): 5746 - 5751
    05/12/1998 Authors: Roberts PC; Compans RW
  • The short Sendai virus leader region controls induction of programmed cell death.
    Virology Volume: 243 Page(s): 340 - 353
    04/10/1998 Authors: Garcin D; Taylor G; Tanebayashi K; Compans R; Kolakofsky D
  • Evidence for cooperation between murine leukemia virus Env molecules in mixed oligomers.
    J Virol Volume: 72 Page(s): 3432 - 3435
    04/01/1998 Authors: Rein A; Yang C; Haynes JA; Mirro J; Compans RW
  • Role of actin microfilaments in Black Creek Canal virus morphogenesis.
    J Virol Volume: 72 Page(s): 2865 - 2870
    04/01/1998 Authors: Ravkov EV; Nichol ST; Peters CJ; Compans RW
  • Population biology, evolution, and immunology of vaccination and vaccination programs.
    Am J Med Sci Volume: 315 Page(s): 76 - 86
    02/01/1998 Authors: Halloran ME; Anderson RM; Azevedo-Neto RS; Bellini WJ; Branch O; Burke MA; Compans R; Day K; Gooding L; Gupta S
  • Function of the KKXX motif in endoplasmic reticulum retrieval of a transmembrane protein depends on the length and structure of the cytoplasmic domain.
    J Biol Chem Volume: 273 Page(s): 950 - 956
    01/09/1998 Authors: Vincent MJ; Martin AS; Compans RW
  • The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation.
    Virology Volume: 240 Page(s): 127 - 137
    01/05/1998 Authors: Roberts PC; Lamb RA; Compans RW
  • Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity.
    J Virol Volume: 71 Page(s): 8490 - 8496
    11/01/1997 Authors: Yang C; Compans RW
  • Polarized apical targeting directed by the signal/anchor region of simian virus 5 hemagglutinin-neuraminidase.
    J Biol Chem Volume: 272 Page(s): 27598 - 27604
    10/31/1997 Authors: Huang XF; Compans RW; Chen S; Lamb RA; Arvan P
  • Adaptation of measles virus to polarized epithelial cells: Alterations in virus entry and release (vol 231, pg 281, 1997)
    VIROLOGY Volume: 236 Page(s): 219 - 219
    09/15/1997 Authors: Blau DM; Compans RW
  • Upregulation of signalase processing and induction of prM-E secretion by the flavivirus NS2B-NS3 protease: roles of protease components.
    J Virol Volume: 71 Page(s): 4364 - 4371
    06/01/1997 Authors: Yamshchikov VF; Trent DW; Compans RW
  • Basolateral sorting of the HIV type 2 and SIV envelope glycoproteins in polarized epithelial cells: role of the cytoplasmic domain.
    AIDS Res Hum Retroviruses Volume: 13 Page(s): 665 - 675
    05/20/1997 Authors: Ball JM; Mulligan MJ; Compans RW
  • Adaptation of measles virus to polarized epithelial cells: alterations in virus entry and release.
    Virology Volume: 231 Page(s): 281 - 289
    05/12/1997 Authors: Blau DM; Compans RW
  • Polarized entry and release in epithelial cells of Black Creek Canal virus, a New World hantavirus.
    J Virol Volume: 71 Page(s): 1147 - 1154
    02/01/1997 Authors: Ravkov EV; Nichol ST; Compans RW
  • Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces.
    J Virol Volume: 71 Page(s): 650 - 656
    01/01/1997 Authors: Yao Q; Hu X; Compans RW
  • Characterization of a novel baboon virus closely resembling human T-cell leukemia virus.
    Virology Volume: 226 Page(s): 57 - 65
    12/01/1996 Authors: Vincent MJ; Novembre FJ; Yamshchikov VF; McClure HM; Compans RW
  • Molecular determinants of Golgi retention in the Punta Toro virus G1 protein.
    Arch Biochem Biophys Volume: 336 Page(s): 184 - 189
    12/01/1996 Authors: Matsuoka Y; Chen SY; Holland CE; Compans RW
  • Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion.
    J Virol Volume: 70 Page(s): 6112 - 6118
    09/01/1996 Authors: Tanabayashi K; Compans RW
  • Introduction: rotavirus--from basic research to a vaccine.
    J Infect Dis Volume: 174 Suppl 1 Page(s): S1 - S2
    09/01/1996 Authors: Glass RI; Lang DR; Ivanoff BN; Compans RW
  • Summary of the Fifth Rotavirus Vaccine Workshop.
    J Infect Dis Volume: 174 Suppl 1 Page(s): S3 - S4
    09/01/1996 Authors: Lang DR; Glass RI; Compans RW
  • Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.
    Virology Volume: 223 Page(s): 103 - 112
    09/01/1996 Authors: Yao Q; Compans RW
  • Assembly and release of SIV env proteins with full-length or truncated cytoplasmic domains.
    Virology Volume: 221 Page(s): 22 - 33
    07/01/1996 Authors: Vzorov AN; Compans RW
  • Palmitoylation of the murine leukemia virus envelope glycoprotein transmembrane subunits.
    Virology Volume: 221 Page(s): 87 - 97
    07/01/1996 Authors: Yang C; Compans RW
  • Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.
    J Virol Volume: 70 Page(s): 2643 - 2649
    04/01/1996 Authors: Porter DC; Melsen LR; Compans RW; Morrow CD
  • Effect of influenza A virus M2 protein on virus assembly and release
    Volume: 1123 Page(s): 351 - 356
    01/01/1996 Authors: Roberts PC; Hughey PG; Holsinger LJ; Lamb RA; Compans RW
  • Mucosal immunization against influenza virus using bioadhesive polymers
    Volume: 1123 Page(s): 271 - 277
    01/01/1996 Authors: OhlssonWilhelm BM; Duncan J; Mestecky J; Compans RW
  • A tissue culture model of viral persistence for an orthomyxovirus
    Volume: 1123 Page(s): 455 - 460
    01/01/1996 Authors: Marschall M; Schuler A; Hechtfischer A; Helten A; Boswald C; MeierEwert H; Blau DM; Roberts PC; Compans RW
  • Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide.
    J Virol Volume: 70 Page(s): 248 - 254
    01/01/1996 Authors: Yang C; Compans RW
  • Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system.
    Virology Volume: 214 Page(s): 50 - 58
    12/01/1995 Authors: Yamshchikov GV; Ritter GD; Vey M; Compans RW
  • Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins.
    J Virol Volume: 69 Page(s): 7045 - 7053
    11/01/1995 Authors: Yao Q; Compans RW
  • The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated.
    Proc Natl Acad Sci U S A Volume: 92 Page(s): 9871 - 9875
    10/10/1995 Authors: Yang C; Spies CP; Compans RW
  • Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly.
    Virology Volume: 212 Page(s): 411 - 421
    10/01/1995 Authors: Hughey PG; Roberts PC; Holsinger LJ; Zebedee SL; Lamb RA; Compans RW
  • Entry and release of measles virus are polarized in epithelial cells.
    Virology Volume: 210 Page(s): 91 - 99
    06/20/1995 Authors: Blau DM; Compans RW
  • Oligomerization of the hydrophobic heptad repeat of gp41.
    J Virol Volume: 69 Page(s): 2745 - 2750
    05/01/1995 Authors: Bernstein HB; Tucker SP; Kar SR; McPherson SA; McPherson DT; Dubay JW; Lebowitz J; Compans RW; Hunter E
  • Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease.
    J Virol Volume: 69 Page(s): 1995 - 2003
    04/01/1995 Authors: Yamshchikov VF; Compans RW
  • Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells.
    J Virol Volume: 69 Page(s): 2667 - 2673
    04/01/1995 Authors: Roberts SR; Compans RW; Wertz GW
  • ROLE OF THE CYTOPLASMIC TAIL OF THE PARAINFLUENZA VIRUS F-PROTEIN
    FASEB JOURNAL Volume: 9 Page(s): A544 - A544
    03/09/1995 Authors: YAO QZ; COMPANS RW
  • A polarized human endometrial cell line that binds and transports polymeric IgA.
    In Vitro Cell Dev Biol Anim Volume: 31 Page(s): 196 - 206
    03/01/1995 Authors: Ball JM; Moldoveanu Z; Melsen LR; Kozlowski PA; Jackson S; Mulligan MJ; Mestecky JF; Compans RW
  • Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding.
    J Virol Volume: 69 Page(s): 1099 - 1106
    02/01/1995 Authors: Liu C; Eichelberger MC; Compans RW; Air GM
  • MUCOSAL IMMUNIZATION WITH CHLAMYDIAL ANTIGENS
    JOURNAL OF CELLULAR BIOCHEMISTRY Page(s): 248 - 248
    01/05/1995 Authors: NOVAK M; MCNAMARA R; DUNCAN JD; MOLDOVEANU Z; COMPANS RW; MESTECKY J
  • Virus entry and release in polarized epithelial cells.
    Curr Top Microbiol Immunol Volume: 202 Page(s): 209 - 219
    01/01/1995 Authors: Compans RW
  • Compartmentalization within the common mucosal immune system.
    Adv Exp Med Biol Volume: 371A Page(s): 97 - 101
    01/01/1995 Authors: Moldoveanu Z; Russell MW; Wu HY; Huang WQ; Compans RW; Mestecky J
  • Generation of long flavivirus expression cassettes by in vivo recombination and transient dominant selection.
    Gene Volume: 149 Page(s): 193 - 201
    11/18/1994 Authors: Yamshchikov VF; Compans RW
  • Calmodulin antagonists inhibit human immunodeficiency virus-induced cell fusion but not virus replication.
    AIDS Res Hum Retroviruses Volume: 10 Page(s): 1489 - 1496
    11/01/1994 Authors: Srinivas RV; Bernstein H; Oliver C; Compans RW
  • Mucosal immunity and strategies for novel microbial vaccines.
    Acta Paediatr Jpn Volume: 36 Page(s): 537 - 544
    10/01/1994 Authors: Mestecky J; Moldoveanu Z; Novak M; Compans RW
  • A signal for Golgi retention in the bunyavirus G1 glycoprotein.
    J Biol Chem Volume: 269 Page(s): 22565 - 22573
    09/09/1994 Authors: Matsuoka Y; Chen SY; Compans RW
  • Virus-like particles in MDCK cells persistently infected with Borna disease virus.
    Virus Res Volume: 33 Page(s): 261 - 268
    09/01/1994 Authors: Compans RW; Melsen LR; de la Torre JC
  • Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study.
    J Virol Volume: 68 Page(s): 5765 - 5771
    09/01/1994 Authors: Yamshchikov VF; Compans RW
  • Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein.
    Virology Volume: 203 Page(s): 8 - 19
    08/15/1994 Authors: Spies CP; Compans RW
  • PROTECTION AGAINST VAGINAL TRANSMISSION OF SIV BY MUCOSAL IMMUNIZATION WITH VACCINE IN BIODEGRADABLE MICROSPHERES
    AIDS RESEARCH AND HUMAN RETROVIRUSES Volume: 10 Page(s): S43 - S43
    08/01/1994 Authors: ELDRIDGE JH; MARX PA; COMPANS RW; GETTIE A; STAAS JK; GILLEY RM; CHEN D
  • Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain.
    J Virol Volume: 68 Page(s): 585 - 591
    02/01/1994 Authors: Spies CP; Ritter GD; Mulligan MJ; Compans RW
  • Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides.
    J Virol Volume: 68 Page(s): 463 - 468
    01/01/1994 Authors: Bernstein HB; Tucker SP; Hunter E; Schutzbach JS; Compans RW
  • EXPRESSION OF VIRAL RECEPTORS AND THE VECTORIAL RELEASE OF VIRUSES IN POLARIZED EPITHELIAL CELLS
    Page(s): 323 - 340
    01/01/1994 Authors: TUCKER SP; WIMMER E; COMPANS RW
  • Viruses as model systems in cell biology.
    Methods Cell Biol Volume: 43 Pt A Page(s): 3 - 42
    01/01/1994 Authors: Compans RW; Roberts PC
  • Alternate pathways of secretion of simian immunodeficiency virus envelope glycoproteins.
    J Virol Volume: 67 Page(s): 6535 - 6541
    11/01/1993 Authors: Spies CP; Compans RW
  • Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain.
    Virology Volume: 197 Page(s): 255 - 264
    11/01/1993 Authors: Ritter GD; Mulligan MJ; Lydy SL; Compans RW
  • Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins.
    J Biol Chem Volume: 268 Page(s): 22895 - 22899
    10/25/1993 Authors: Srinivas SK; Srinivas RV; Anantharamaiah GM; Compans RW; Segrest JP
  • INACTIVATED SIV IN BIODEGRADABLE MICROSPHERES PROTECTS RHESUS MACAQUES FROM VAGINAL CHALLENGE
    AIDS RESEARCH AND HUMAN RETROVIRUSES Volume: 9 Page(s): S38 - S38
    10/01/1993 Authors: MARX PA; GETTIE A; ELDRIDGE JH; STAAS JK; GILLEY RM; MULLIGAN MJ; MESTECKY J; COMPANS RW
  • Role of the cytoplasmic domains of viral glycoproteins in antibody-induced cell surface mobility.
    J Virol Volume: 67 Page(s): 6289 - 6294
    10/01/1993 Authors: Lydy SL; Compans RW
  • Vectorial release of poliovirus from polarized human intestinal epithelial cells.
    J Virol Volume: 67 Page(s): 4274 - 4282
    07/01/1993 Authors: Tucker SP; Thornton CL; Wimmer E; Compans RW
  • Protection against vaginal SIV transmission with microencapsulated vaccine.
    Science Volume: 260 Page(s): 1323 - 1327
    05/28/1993 Authors: Marx PA; Compans RW; Gettie A; Staas JK; Gilley RM; Mulligan MJ; Yamshchikov GV; Chen D; Eldridge JH
  • Microencapsulated human parainfluenza virus induces a protective immune response.
    J Infect Dis Volume: 167 Page(s): 752 - 755
    03/01/1993 Authors: Ray R; Novak M; Duncan JD; Matsuoka Y; Compans RW
  • Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein.
    Virology Volume: 193 Page(s): 510 - 514
    03/01/1993 Authors: Hallenberger S; Tucker SP; Owens RJ; Bernstein HB; Compans RW
  • Regulation of the late events in flavivirus protein processing and maturation.
    Virology Volume: 192 Page(s): 38 - 51
    01/01/1993 Authors: Yamshchikov VF; Compans RW
  • Virus infection of polarized epithelial cells.
    Adv Virus Res Volume: 42 Page(s): 187 - 247
    01/01/1993 Authors: Tucker SP; Compans RW
  • Murine model for evaluation of protective immunity to influenza virus.
    Vaccine Volume: 11 Page(s): 55 - 60
    01/01/1993 Authors: Novak M; Moldoveanu Z; Schafer DP; Mestecky J; Compans RW
  • Oral immunization with influenza virus in biodegradable microspheres.
    J Infect Dis Volume: 167 Page(s): 84 - 90
    01/01/1993 Authors: Moldoveanu Z; Novak M; Huang WQ; Gilley RM; Staas JK; Schafer D; Compans RW; Mestecky J
  • Bidirectional entry of poliovirus into polarized epithelial cells.
    J Virol Volume: 67 Page(s): 29 - 38
    01/01/1993 Authors: Tucker SP; Thornton CL; Wimmer E; Compans RW
  • INTERACTION OF VIRUSES WITH POLARIZED EPITHELIAL-CELLS
    Page(s): 323 - 332
    01/01/1993 Authors: COMPANS RW; TUCKER SP; OWENS RJ
  • Sulfation of the human immunodeficiency virus envelope glycoprotein.
    J Virol Volume: 66 Page(s): 6953 - 6959
    12/01/1992 Authors: Bernstein HB; Compans RW
  • Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus.
    J Virol Volume: 66 Page(s): 7104 - 7112
    12/01/1992 Authors: Wu X; Chen SY; Iwata H; Compans RW; Roy P
  • A carboxy-terminal mutant spleen focus-forming virus (SFFV) envelope glycoprotein is transport-competent, but non-leukemogenic.
    Virus Res Volume: 26 Page(s): 57 - 69
    10/01/1992 Authors: Srinivas RV; Rui Z; Compans RW
  • Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells.
    J Virol Volume: 66 Page(s): 5542 - 5552
    09/01/1992 Authors: Hughey PG; Compans RW; Zebedee SL; Lamb RA
  • Expression of SV40 receptors on apical surfaces of polarized epithelial cells.
    Virology Volume: 190 Page(s): 393 - 402
    09/01/1992 Authors: Basak S; Turner H; Compans RW
  • Isotype of anti-SIV responses in infected rhesus macaques and in animals immunized by mucosal routes.
    AIDS Res Hum Retroviruses Volume: 8 Page(s): 1389
    08/01/1992 Authors: McGhee JR; Yamamoto M; Kang DW; Eldridge JH; Mestecky J; Moldoveanu Z; Compans R; Kiyono H; Miller C; Marthas M
  • Migration of polarized epithelial cells through permeable membrane substrates of defined pore size.
    Eur J Cell Biol Volume: 58 Page(s): 280 - 290
    08/01/1992 Authors: Tucker SP; Melsen LR; Compans RW
  • Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types.
    J Virol Volume: 66 Page(s): 3971 - 3975
    06/01/1992 Authors: Mulligan MJ; Yamshchikov GV; Ritter GD; Gao F; Jin MJ; Nail CD; Spies CP; Hahn BH; Compans RW
  • A 585-bp deletion found in the spleen focus-forming virus (SFFV) env gene is responsible for the defective intracellular transport of SFFV gp52.
    Virology Volume: 188 Page(s): 181 - 192
    05/01/1992 Authors: Srinivas RV; Tucker SP; Kilpatrick DR; Compans RW
  • Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein.
    J Biol Chem Volume: 267 Page(s): 7121 - 7127
    04/05/1992 Authors: Srinivas SK; Srinivas RV; Anantharamaiah GM; Segrest JP; Compans RW
  • The NS and capsid genes determine the host range of porcine parvovirus.
    Virology Volume: 187 Page(s): 515 - 524
    04/01/1992 Authors: Vasudevacharya J; Compans RW
  • Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses.
    J Virol Volume: 66 Page(s): 1528 - 1534
    03/01/1992 Authors: Hu XL; Ray R; Compans RW
  • Assembly of G1 and G2 glycoprotein oligomers in Punta Toro virus-infected cells.
    Virus Res Volume: 22 Page(s): 215 - 225
    03/01/1992 Authors: Chen SY; Matsuoka Y; Compans RW
  • Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
    Virology Volume: 187 Page(s): 233 - 241
    03/01/1992 Authors: Mulligan MJ; Ritter GD; Chaikin MA; Yamshchikov GV; Kumar P; Hahn BH; Sweet RW; Compans RW
  • The parainfluenza virus type 1 P/C gene uses a very efficient GUG codon to start its C' protein.
    J Virol Volume: 66 Page(s): 1765 - 1768
    03/01/1992 Authors: Boeck R; Curran J; Matsuoka Y; Compans R; Kolakofsky D
  • HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 ENVELOPE GLYCOPROTEIN - DIFFERENTIAL CD4 INTERACTIONS OF SOLUBLE GP120 VERSUS THE ASSEMBLED ENVELOPE COMPLEX
    CLINICAL RESEARCH Volume: 39 Page(s): A861 - A861
    12/01/1991 Authors: MULLIGAN MJ; RITTER GD; CHAIKIN MA; YAMSHCHIKOV GV; HAHN BH; SWEET RW; COMPANS RW
  • Molecular domains involved in oligomerization of the Friend murine leukemia virus envelope glycoprotein.
    Virology Volume: 185 Page(s): 710 - 720
    12/01/1991 Authors: Tucker SP; Srinivas RV; Compans RW
  • Oligomerization, transport, and Golgi retention of Punta Toro virus glycoproteins.
    J Virol Volume: 65 Page(s): 5902 - 5909
    11/01/1991 Authors: Chen SY; Compans RW
  • Inhibition of human immunodeficiency virus type 1-induced cell fusion by recombinant human interferons.
    J Virol Volume: 65 Page(s): 6325 - 6330
    11/01/1991 Authors: Wells DE; Chatterjee S; Mulligan MJ; Compans RW
  • The hydrophobic membrane-spanning sequences of the gp52 glycoprotein are required for the pathogenicity of Friend spleen focus-forming virus.
    J Virol Volume: 65 Page(s): 5272 - 5280
    10/01/1991 Authors: Srinivas RV; Kilpatrick DR; Tucker S; Rui Z; Compans RW
  • Isolation of an arenavirus from a marmoset with callitrichid hepatitis and its serologic association with disease.
    J Virol Volume: 65 Page(s): 3995 - 4000
    08/01/1991 Authors: Stephensen CB; Jacob JR; Montali RJ; Holmes KV; Muchmore E; Compans RW; Arms ED; Buchmeier MJ; Lanford RE
  • Golgi complex localization of the Punta Toro virus G2 protein requires its association with the G1 protein.
    Virology Volume: 183 Page(s): 351 - 365
    07/01/1991 Authors: Chen SY; Matsuoka Y; Compans RW
  • The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein.
    J Virol Volume: 65 Page(s): 3406 - 3410
    06/01/1991 Authors: Matsuoka Y; Curran J; Pelet T; Kolakofsky D; Ray R; Compans RW
  • Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells.
    Proc Natl Acad Sci U S A Volume: 88 Page(s): 3987 - 3991
    05/01/1991 Authors: Owens RJ; Dubay JW; Hunter E; Compans RW
  • The three-dimensional structure of canine parvovirus and its functional implications.
    Science Volume: 251 Page(s): 1456 - 1464
    03/22/1991 Authors: Tsao J; Chapman MS; Agbandje M; Keller W; Smith K; Wu H; Luo M; Smith TJ; Rossmann MG; Compans RW
  • Assembly and polarized release of Punta Toro virus and effects of brefeldin A.
    J Virol Volume: 65 Page(s): 1427 - 1439
    03/01/1991 Authors: Chen SY; Matsuoka Y; Compans RW
  • Inhibition of virus-induced cell fusion by apolipoprotein A-I and its amphipathic peptide analogs.
    J Cell Biochem Volume: 45 Page(s): 224 - 237
    02/01/1991 Authors: Srinivas RV; Venkatachalapathi YV; Rui Z; Owens RJ; Gupta KB; Srinivas SK; Anantharamaiah GM; Segrest JP; Compans RW
  • Protein sorting in polarized epithelial cells.
    Curr Top Microbiol Immunol Volume: 170 Page(s): 141 - 181
    01/01/1991 Authors: Compans RW; Srinivas RV
  • Bunyavirus protein transport and assembly.
    Curr Top Microbiol Immunol Volume: 169 Page(s): 161 - 179
    01/01/1991 Authors: Matsuoka Y; Chen SY; Compans RW
  • The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing.
    Virology Volume: 179 Page(s): 827 - 833
    12/01/1990 Authors: Owens RJ; Compans RW
  • Host cell-dependent lateral mobility of viral glycoproteins.
    Microb Pathog Volume: 9 Page(s): 375 - 386
    12/01/1990 Authors: Lydy SL; Basak S; Compans RW
  • Molecular cloning and sequence analysis of the fusion glycoprotein gene of human parainfluenza virus type 2.
    Virology Volume: 179 Page(s): 915 - 920
    12/01/1990 Authors: Hu XL; Compans RW; Matsuoka Y; Ray R
  • Oligopeptide inhibitors of HIV-induced syncytium formation.
    AIDS Res Hum Retroviruses Volume: 6 Page(s): 1289 - 1296
    11/01/1990 Authors: Owens RJ; Tanner CC; Mulligan MJ; Srinivas RV; Compans RW
  • The complete nucleotide sequence of an infectious clone of porcine parvovirus, strain NADL-2.
    Virology Volume: 178 Page(s): 611 - 616
    10/01/1990 Authors: Vasudevacharya J; Basak S; Srinivas RV; Compans RW
  • Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation.
    J Clin Invest Volume: 86 Page(s): 1142 - 1150
    10/01/1990 Authors: Owens BJ; Anantharamaiah GM; Kahlon JB; Srinivas RV; Compans RW; Segrest JP
  • Human parainfluenza virus induces a type-specific protective immune response.
    J Infect Dis Volume: 162 Page(s): 746 - 749
    09/01/1990 Authors: Ray R; Matsuoka Y; Burnett TL; Glaze BJ; Compans RW
  • The env protein of an infectious noncytopathic HIV-2 is deficient in syncytium formation.
    AIDS Res Hum Retroviruses Volume: 6 Page(s): 707 - 720
    06/01/1990 Authors: Mulligan MJ; Kumar P; Hui HX; Owens RJ; Ritter GD; Hahn BH; Compans RW
  • Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells.
    Virology Volume: 176 Page(s): 575 - 586
    06/01/1990 Authors: Wells DE; Compans RW
  • Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs.
    Virology Volume: 176 Page(s): 48 - 57
    05/01/1990 Authors: Srinivas RV; Birkedal B; Owens RJ; Anantharamaiah GM; Segrest JP; Compans RW
  • Sequence of the hemagglutinin-neuraminidase gene of human parainfluenza virus type 1.
    Virus Res Volume: 16 Page(s): 107 - 113
    04/01/1990 Authors: Matsuoka Y; Ray R; Compans RW
  • Nontemplated bases at the 5' ends of Tacaribe virus mRNAs.
    Virology Volume: 174 Page(s): 53 - 59
    01/01/1990 Authors: Raju R; Raju L; Hacker D; Garcin D; Compans R; Kolakofsky D
  • Nucleotide sequence analysis of the capsid genes and the right-hand terminal palindrome of porcine parvovirus, strain NADL-2.
    Virology Volume: 173 Page(s): 368 - 377
    12/01/1989 Authors: Vasudevacharya J; Basak S; Srinivas RV; Compans RW
  • ANTIVIRAL EFFECTS OF APOLIPOPROTEIN-A-I
    ARTERIOSCLEROSIS Volume: 9 Page(s): A716 - A716
    09/01/1989 Authors: SRINIVAS RV; ANANTHARAMAIAH GM; OWENS RW; COMPANS RW; SEGREST JP
  • Polarized entry of canine parvovirus in an epithelial cell line.
    J Virol Volume: 63 Page(s): 3164 - 3167
    07/01/1989 Authors: Basak S; Compans RW
  • The spleen focus-forming virus envelope glycoprotein is defective in oligomerization.
    J Biol Chem Volume: 264 Page(s): 10732 - 10737
    06/25/1989 Authors: Kilpatrick DR; Srinivas RV; Compans RW
  • Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis.
    J Virol Volume: 63 Page(s): 2278 - 2288
    05/01/1989 Authors: Clayson ET; Brando LV; Compans RW
  • Characterization of simian virus 40 receptor moieties on the surfaces of Vero C1008 cells.
    J Virol Volume: 63 Page(s): 1095 - 1100
    03/01/1989 Authors: Clayson ET; Compans RW
  • Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells.
    J Virol Volume: 63 Page(s): 978 - 982
    02/01/1989 Authors: Owens RJ; Compans RW
  • Expression of the fusion glycoprotein of human parainfluenza type 3 virus in insect cells by a recombinant baculovirus and analysis of its immunogenic property.
    Virus Res Volume: 12 Page(s): 169 - 180
    02/01/1989 Authors: Ray R; Galinski MS; Compans RW
  • Immune responses to influenza virus in orally and systemically immunized mice.
    Curr Top Microbiol Immunol Volume: 146 Page(s): 91 - 99
    01/01/1989 Authors: Moldoveanu Z; Staas JK; Gilley RM; Ray R; Compans RW; Eldridge JH; Tice TR; Mestecky J
  • Intracellular accumulation of Punta Toro virus glycoproteins expressed from cloned cDNA.
    Virology Volume: 167 Page(s): 251 - 260
    11/01/1988 Authors: Matsuoka Y; Ihara T; Bishop DH; Compans RW
  • Entry of simian virus 40 is restricted to apical surfaces of polarized epithelial cells.
    Mol Cell Biol Volume: 8 Page(s): 3391 - 3396
    08/01/1988 Authors: Clayson ET; Compans RW
  • Expression of the spleen focus-forming virus envelope gene in a polarized epithelial cell line.
    Virology Volume: 164 Page(s): 547 - 550
    06/01/1988 Authors: Kilpatrick DR; Srinivas RV; Compans RW
  • Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3.
    J Infect Dis Volume: 157 Page(s): 648 - 654
    04/01/1988 Authors: Ray R; Glaze BJ; Moldoveanu Z; Compans RW
  • Preliminary X-ray crystallographic analysis of canine parvovirus crystals.
    J Mol Biol Volume: 200 Page(s): 209 - 211
    03/05/1988 Authors: Luo M; Tsao J; Rossmann MG; Basak S; Compans RW
  • Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response.
    J Virol Volume: 62 Page(s): 783 - 787
    03/01/1988 Authors: Ray R; Glaze BJ; Compans RW
  • Assembly of animal viruses at cellular membranes.
    Annu Rev Microbiol Volume: 42 Page(s): 489 - 516
    01/01/1988 Authors: Stephens EB; Compans RW
  • SELECTIVE-INHIBITION OF HIV-1 ENVELOPE GLYCOPROTEIN-INDUCED SYNCYTIUM FORMATION
    ANTIVIRAL RESEARCH Volume: 9 Page(s): 102 - 102
    01/01/1988 Authors: OWENS RJ; COMPANS RW
  • Intracellular transport and leukemogenicity of spleen focus-forming virus envelope glycoproteins with altered transmembrane domains.
    J Virol Volume: 61 Page(s): 4007 - 4011
    12/01/1987 Authors: Srinivas RV; Kilpatrick DR; Compans RW
  • Basolateral expression of a chimeric protein in which the transmembrane and cytoplasmic domains of vesicular stomatitis virus G protein have been replaced by those of the influenza virus hemagglutinin.
    J Biol Chem Volume: 262 Page(s): 16233 - 16240
    11/25/1987 Authors: McQueen NL; Nayak DP; Stephens EB; Compans RW
  • Effects of deletion of the cytoplasmic domain upon surface expression and membrane stability of a viral envelope glycoprotein.
    J Biol Chem Volume: 262 Page(s): 16116 - 16121
    11/25/1987 Authors: Kilpatrick DR; Srinivas RV; Stephens EB; Compans RW
  • Glycoproteins of human parainfluenza virus type 3: affinity purification, antigenic characterization and reconstitution into lipid vesicles.
    J Gen Virol Volume: 68 ( Pt 2) Page(s): 409 - 418
    02/01/1987 Authors: Ray R; Compans RW
  • SORTING AND EXPRESSION OF MODIFIED MURINE LEUKEMIA-VIRUS GLYCOPROTEINS AT RESTRICTED MEMBRANE DOMAINS
    JOURNAL OF CELLULAR BIOCHEMISTRY Page(s): 265 - 265
    01/01/1987 Authors: STEPHENS EB; COMPANS RW
  • SITE-MODIFICATION OF F-SFFV GLYCOPROTEINS
    JOURNAL OF CELLULAR BIOCHEMISTRY Page(s): 207 - 207
    01/01/1987 Authors: SRINIVAS RV; KILPATRICK D; COMPANS RW
  • Nonpolarized expression of a secreted murine leukemia virus glycoprotein in polarized epithelial cells.
    Cell Volume: 47 Page(s): 1053 - 1059
    12/26/1986 Authors: Stephens EB; Compans RW
  • Polarized expression of a chimeric protein in which the transmembrane and cytoplasmic domains of the influenza virus hemagglutinin have been replaced by those of the vesicular stomatitis virus G protein.
    Proc Natl Acad Sci U S A Volume: 83 Page(s): 9318 - 9322
    12/01/1986 Authors: McQueen N; Nayak DP; Stephens EB; Compans RW
  • Expression of herpes simplex virus glycoproteins in polarized epithelial cells.
    J Virol Volume: 58 Page(s): 689 - 693
    05/01/1986 Authors: Srinivas RV; Balachandran N; Alonso-Caplen FV; Compans RW
  • Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectors.
    EMBO J Volume: 5 Page(s): 237 - 245
    02/01/1986 Authors: Stephens EB; Compans RW; Earl P; Moss B
  • Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses.
    Virology Volume: 148 Page(s): 232 - 236
    01/15/1986 Authors: Ray R; Compans RW
  • Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine.
    J Infect Dis Volume: 152 Page(s): 1219 - 1230
    12/01/1985 Authors: Ray R; Brown VE; Compans RW
  • Surface expression of influenza virus neuraminidase, an amino-terminally anchored viral membrane glycoprotein, in polarized epithelial cells.
    Mol Cell Biol Volume: 5 Page(s): 2181 - 2189
    09/01/1985 Authors: Jones LV; Compans RW; Davis AR; Bos TJ; Nayak DP
  • Structure and variation of the influenza C glycoprotein.
    Vaccine Volume: 3 Page(s): 189 - 194
    09/01/1985 Authors: Pfeifer JB; Compans RW
  • Synthesis of Tacaribe virus polypeptides in an in vitro coupled transcription and translation system.
    Virus Res Volume: 2 Page(s): 261 - 271
    04/01/1985 Authors: Boersma DP; Compans RW
  • Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidase.
    Virus Res Volume: 2 Page(s): 61 - 68
    02/01/1985 Authors: Basak S; Tomana M; Compans RW
  • Biochemistry of arenaviruses.
    Curr Top Microbiol Immunol Volume: 114 Page(s): 153 - 175
    01/01/1985 Authors: Compans RW; Bishop DH
  • Replication and morphogenesis of avian coronavirus in Vero cells and their inhibition by monensin.
    Virus Res Volume: 1 Page(s): 153 - 167
    01/01/1984 Authors: Alonso-Caplen FV; Matsuoka Y; Wilcox GE; Compans RW
  • Chimeric influenza virus hemagglutinin containing either the NH2 terminus or the COOH terminus of G protein of vesicular stomatitis virus is defective in transport to the cell surface.
    Proc Natl Acad Sci U S A Volume: 81 Page(s): 395 - 399
    01/01/1984 Authors: McQueen NL; Nayak DP; Jones LV; Compans RW
  • Structure of the influenza C glycoprotein gene as determined from cloned DNA.
    Virus Res Volume: 1 Page(s): 281 - 296
    01/01/1984 Authors: Pfeifer JB; Compans RW
  • DIRECTIONAL TRANSPORT OF HERPES-SIMPLEX TYPE VIRUS (TYPE-II) GLYCOPROTEINS IN POLARIZED EPITHELIAL-CELLS
    JOURNAL OF CELL BIOLOGY Volume: 99 Page(s): A280 - A280
    01/01/1984 Authors: SRINIVAS RV; BALACHANDRAN N; COMPANS RW
  • Membrane association and defective transport of spleen focus-forming virus glycoproteins.
    J Biol Chem Volume: 258 Page(s): 14718 - 14724
    12/10/1983 Authors: Srinivas RV; Compans RW
  • Modulation of glycosylation and transport of viral membrane glycoproteins by a sodium ionophore.
    J Cell Biol Volume: 97 Page(s): 659 - 668
    09/01/1983 Authors: Alonso-Caplen FV; Compans RW
  • Posttranslational modification and intracellular transport of mumps virus glycoproteins.
    J Virol Volume: 47 Page(s): 354 - 362
    08/01/1983 Authors: Herrler G; Compans RW
  • Analysis of polypeptides in Tacaribe virus-infected cells.
    Virology Volume: 128 Page(s): 469 - 473
    07/30/1983 Authors: Gimenez HB; Boersma DP; Compans RW
  • Studies on the role of glycosylation in the functions and antigenic properties of influenza virus glycoproteins.
    Virology Volume: 128 Page(s): 77 - 91
    07/15/1983 Authors: Basak S; Compans RW
  • Influenza virus hemagglutinin expression is polarized in cells infected with recombinant SV40 viruses carrying cloned hemagglutinin DNA.
    Cell Volume: 33 Page(s): 435 - 443
    06/01/1983 Authors: Roth MG; Compans RW; Giusti L; Davis AR; Nayak DP; Gething MJ; Sambrook J
  • Glycosylation and intracellular transport of spleen focus-forming virus glycoproteins.
    Virology Volume: 125 Page(s): 274 - 286
    03/01/1983 Authors: Srinivas RV; Compans RW
  • Effects of hexose starvation and the role of sialic acid in influenza virus release.
    Virology Volume: 125 Page(s): 324 - 334
    03/01/1983 Authors: Griffin JA; Basak S; Compans RW
  • Immune response to human influenza virus hemagglutinin expressed in Escherichia coli.
    Gene Volume: 21 Page(s): 273 - 284
    03/01/1983 Authors: Davis AR; Bos T; Ueda M; Nayak DP; Dowbenko D; Compans RW
  • Basolateral maturation of retroviruses in polarized epithelial cells.
    J Virol Volume: 45 Page(s): 1065 - 1073
    03/01/1983 Authors: Roth MG; Srinivas RV; Compans RW
  • GLYCOSYLATION AND TRANSPORT OF 2 VIRAL MEMBRANE-GLYCOPROTEINS THAT ARE ANCHORED BY AMINO-TERMINAL SIGNAL PEPTIDE SEQUENCES
    JOURNAL OF CELL BIOLOGY Volume: 97 Page(s): A444 - A444
    01/01/1983 Authors: SRINIVAS RV; ALONSOCAPLEN FV; COMPANS RW
  • POSTTRANSLATIONAL MODIFICATION OF MUMPS-VIRUS GLYCOPROTEINS
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY Volume: 255 Page(s): 171 - 172
    01/01/1983 Authors: HERRLER G; COMPANS RW
  • Structure and glycosylation of Tacaribe viral glycoproteins.
    Virology Volume: 123 Page(s): 452 - 456
    12/01/1982 Authors: Boersma DP; Saleh F; Nakamura K; Compans RW
  • Selective dansylation of M protein within intact influenza virions.
    J Virol Volume: 44 Page(s): 871 - 876
    12/01/1982 Authors: Robertson BH; Bennett JC; Compans RW
  • Cell fusion induced by Nelson Bay virus.
    Virology Volume: 123 Page(s): 312 - 322
    12/01/1982 Authors: Wilcox GE; Compans RW
  • Nucleotide sequence conservation at the 3' termini of the virion RNA species of New World and Old World arenaviruses.
    Virology Volume: 121 Page(s): 200 - 203
    08/01/1982 Authors: Auperin DD; Compans RW; Bishop DH
  • Immunologic studies on the influenza A virus nonstructural protein NS1.
    J Exp Med Volume: 156 Page(s): 243 - 254
    07/01/1982 Authors: Shaw MW; Lamon EW; Compans RW
  • Effects of monensin on morphogenesis and infectivity of Friend murine leukemia virus.
    J Virol Volume: 42 Page(s): 1067 - 1075
    06/01/1982 Authors: Srinivas RV; Melsen LR; Compans RW
  • Synthesis of mumps virus polypeptides in infected Vero cells.
    Virology Volume: 119 Page(s): 430 - 438
    06/01/1982 Authors: Herrler G; Compans RW
  • Effect of tunicamycin on the replication of Sendai virus.
    Virology Volume: 119 Page(s): 474 - 487
    06/01/1982 Authors: Nakamura K; Homma M; Compans RW
  • Structural domains of vesicular stomatitis virus. A study by differential scanning calorimetry, thermal gel analysis, and thermal electron microscopy.
    J Biol Chem Volume: 257 Page(s): 12 - 15
    01/10/1982 Authors: Brouillette CG; Compans RW; Brandts JF; Segrest JP
  • EFFECTS OF MONENSIN AND TUNICAMYCIN ON ENVELOPED VIRUSES THAT FORM AT ROUGH ENDOPLASMIC-RETICULUM AND GOLGI MEMBRANES
    JOURNAL OF CELL BIOLOGY Volume: 95 Page(s): A394 - A394
    01/01/1982 Authors: ALONSO FV; MATSUOKA Y; COMPANS RW
  • Structural domains in vesicular stomatitis virus membrane as studied by differential scanning calorimetry.
    Biophys J Volume: 37 Page(s): 25 - 26
    01/01/1982 Authors: Brouillette CG; Compans RW; Segrest JP; Brandts JF
  • Characterization of glycosaminoglycans associated with Rauscher murine leukemia virions.
    Membr Biochem Volume: 4 Page(s): 219 - 234
    01/01/1982 Authors: Kemp MC; Compans RW; Caterson B; Baker JR
  • Surface expression of a nonstructural antigen on influenza A virus-infected cells.
    Infect Immun Volume: 34 Page(s): 1065 - 1067
    12/01/1981 Authors: Shaw MW; Lamon EW; Compans RW
  • Delayed appearance of pseudotypes between vesicular stomatitis virus influenza virus during mixed infection of MDCK cells.
    J Virol Volume: 40 Page(s): 848 - 860
    12/01/1981 Authors: Roth MG; Compans RW
  • Isolation and structural analysis of influenza C virion glycoproteins.
    Virology Volume: 113 Page(s): 439 - 451
    09/01/1981 Authors: Herrler G; Nagele A; Meier-Ewert H; Bhown AS; Compans RW
  • Glycoproteins of murine leukemia viruses. III. Glycosylation of env precursor glycoproteins.
    J Virol Volume: 39 Page(s): 463 - 470
    08/01/1981 Authors: Kemp MC; Famulari NG; Compans RW
  • Oligonucleotide fingerprint analysis of Tacaribe virion RNA.
    J Gen Virol Volume: 55 Page(s): 219 - 222
    07/01/1981 Authors: Gimenez HB; Compans RW
  • Differential effect of monensin on enveloped viruses that form at distinct plasma membrane domains.
    J Cell Biol Volume: 89 Page(s): 700 - 705
    06/01/1981 Authors: Alonso FV; Compans RW
  • Characterization of the RNA associated with influenza A cytoplasmic inclusions and the interaction of NS1 protein with RNA.
    Virology Volume: 110 Page(s): 87 - 97
    04/15/1981 Authors: Yoshida T; Shaw MW; Young JF; Compans RW
  • Glycosylation sites of influenza viral glycoproteins: characterization of tryptic glycopeptides from the A/USSR(H1N1) hemagglutinin glycoprotein.
    J Virol Volume: 37 Page(s): 549 - 558
    02/01/1981 Authors: Basak S; Pritchard DG; Bhown AS; Compans RW
  • MOLECULAR STUDIES ON THE INTRACELLULAR-TRANSPORT OF VIRAL MEMBRANE-GLYCOPROTEINS USING MONENSIN AS A PROBE
    JOURNAL OF CELL BIOLOGY Volume: 91 Page(s): A392 - A392
    01/01/1981 Authors: ALONSO FV; COMPANS RW
  • STRUCTURAL DOMAINS IN VESICULAR STOMATITIS-VIRUS AS STUDIED BY DIFFERENTIAL SCANNING CALORIMETRY
    FEDERATION PROCEEDINGS Volume: 40 Page(s): 569 - 569
    01/01/1981 Authors: BROUILLETTE CG; COMPANS RW; BRANDTS JF
  • Glycosylation sites of influenza viral glycoproteins. Tryptic glycopeptides from the A/WSN (H0N1) hemagglutinin glycoprotein.
    Virology Volume: 107 Page(s): 208 - 221
    11/01/1980 Authors: Nakamura K; Bhown AS; Compans RW
  • Defective interfering Tacaribe virus and persistently infected cells.
    Virology Volume: 107 Page(s): 229 - 239
    11/01/1980 Authors: Gimenez HB; Compans RW
  • Antibody-resistant spread of vesicular stomatitis virus infection in cell lines of epithelial origin.
    J Virol Volume: 35 Page(s): 547 - 550
    08/01/1980 Authors: Roth MG; Compans RW
  • Separation of influenza hemagglutinin tryptic glycopeptides by ion-pair reverse-phase high-performance liquid chromatography (HPLC).
    J Biochem Biophys Methods Volume: 3 Page(s): 61 - 63
    07/01/1980 Authors: Kemp MC; Hollaway WL; Bennett JC; Compans RW
  • Glycopeptides of murine leukemia viruses. II. Comparison of xenotropic and dual-tropic viruses.
    J Virol Volume: 34 Page(s): 154 - 161
    04/01/1980 Authors: Kemp MC; Famulari NG; O'Donnell PV; Compans RW
  • Inhibition of influenza C virus replication by actinomycin D, alpha-amanitin, and UV irradiation.
    J Virol Volume: 32 Page(s): 1037 - 1040
    12/01/1979 Authors: Petri T; Meier-Ewert H; Compans RW
  • Polarity of influenza and vesicular stomatitis virus maturation in MDCK cells: lack of a requirement for glycosylation of viral glycoproteins.
    Proc Natl Acad Sci U S A Volume: 76 Page(s): 6430 - 6434
    12/01/1979 Authors: Roth MG; Fitzpatrick JP; Compans RW
  • A precursor glycoprotein in influenza C virus.
    Virology Volume: 99 Page(s): 49 - 56
    11/01/1979 Authors: Herrler G; Compans RW; Meier-Ewert H
  • Effect of cytochalasin B on the maturation of enveloped viruses.
    J Exp Med Volume: 150 Page(s): 379 - 391
    08/01/1979 Authors: Griffin JA; Compans RW
  • Glycopeptides of murine leukemia viruses. I. Comparison of two ecotropic viruses.
    J Virol Volume: 31 Page(s): 1 - 7
    07/01/1979 Authors: Kemp MC; Basak S; Compans RW
  • Structure of the membrane protein of influenza virus. I. Isolation and characterization of cyanogen bromide cleavage products.
    J Virol Volume: 30 Page(s): 759 - 766
    06/01/1979 Authors: Robertson BH; Bhown AS; Compans RW; Bennett JC
  • Host cell- and virus strain-dependent differences in oligosaccharides of hemagglutinin glycoproteins of influenza A viruses.
    Virology Volume: 95 Page(s): 8 - 23
    05/01/1979 Authors: Nakamura K; Compans RW
  • Carbohydrate components of influenza C virions.
    J Virol Volume: 29 Page(s): 997 - 1005
    03/01/1979 Authors: Nakamura K; Herrler G; Petri T; Meier-Ewert H; Compans RW
  • Synthesis of tacaribe viral proteins.
    Virology Volume: 93 Page(s): 369 - 376
    03/01/1979 Authors: Saleh F; Gard GP; Compans RW
  • Biosynthesis of the oligosaccharides of influenza viral glycoproteins.
    Virology Volume: 93 Page(s): 31 - 47
    02/01/1979 Authors: Nakamura N; Compans RW
  • STUDIES ON THE INFLUENZA A VIRUS NONSTRUCTURAL PROTEIN USING RABBIT ANTIBODY
    FEDERATION PROCEEDINGS Volume: 38 Page(s): 910 - 910
    01/01/1979 Authors: SHAW MW; LAMON EW; COMPANS RW
  • COMPARATIVE ANALYSIS OF THE OLIGOSACCHARIDE MOIETIES OF XENOTROPIC AND ECOTROPIC MURINE LEUKEMIA VIRUSES (MULV)
    JOURNAL OF SUPRAMOLECULAR STRUCTURE Page(s): 207 - 207
    01/01/1979 Authors: KEMP MC; BASAK S; COMPANS RW
  • DEPRESSED SPECIFIC ANTIBODY-RESPONSE IN MICE INDUCED BY PRIMARY INOCULATION WITH POLYOMA TUMOR-CELLS
    FEDERATION PROCEEDINGS Volume: 38 Page(s): 1177 - 1177
    01/01/1979 Authors: COX BA; LAMON EW; COMPANS RW
  • Viral membranes: model systems for studying biological membranes.
    CRC Crit Rev Biochem Volume: 6 Page(s): 165 - 217
    01/01/1979 Authors: Patzer EJ; Wagner RR; Dubovi EJ
  • Structural components of mouse mammary tumor virus. III. Composition and tryptic peptides of virion polypeptides.
    Virology Volume: 91 Page(s): 291 - 304
    12/01/1978 Authors: Yagi MJ; Tomana M; Stutzman RE; Robertson BH; Compans RW
  • Origin of the minor glycoproteins of murine leukemia viruses.
    J Virol Volume: 28 Page(s): 84 - 94
    10/01/1978 Authors: Kemp MC; Wise KS; Edlund LE; Acton RT; Compans RW
  • Glycopeptide components of influenza viral glycoproteins.
    Virology Volume: 86 Page(s): 432 - 442
    05/15/1978 Authors: Nakamura K; Compans RW
  • Virion RNA species of the arenaviruses Pichinde, Tacaribe, and Tamiami.
    J Virol Volume: 26 Page(s): 485 - 497
    05/01/1978 Authors: Vezza AC; Clewley JP; Gard GP; Abraham NZ; Compans RW; Bishop DH
  • Structural components of mouse mammary tumor virus. II. Isolation and purification of virion polypeptides.
    J Virol Volume: 26 Page(s): 448 - 456
    05/01/1978 Authors: Yagi MJ; Stutzman RE; Robertson BH; Compans RW
  • Isolation and characterization of cytoplasmic inclusions from influenza A virus-infected cells.
    J Virol Volume: 25 Page(s): 608 - 615
    02/01/1978 Authors: Shaw MW; Compans RW
  • Effects of glucosamine, 2-deoxyglucose, and tunicamycin on glycosylation, sulfation, and assembly of influenza viral proteins.
    Virology Volume: 84 Page(s): 303 - 319
    02/01/1978 Authors: Nakamura K; Compans RW
  • GLYCOSYLATION AND ASSEMBLY OF VIRAL MEMBRANE GLYCOPROTEINS
    FEDERATION PROCEEDINGS Volume: 37 Page(s): 1772 - 1772
    01/01/1978 Authors: COMPANS RW; GRIFFIN JA; NAKAMURA K
  • EFFECTS OF CYTOCHALASIN-B ON MATURATION OF ENVELOPED VIRUSES
    ALABAMA JOURNAL OF MEDICAL SCIENCES Volume: 15 Page(s): 269 - 269
    01/01/1978 Authors: GRIFFIN JA; COMPANS RW
  • Membrane Glycoproteins of Enveloped Viruses.
    Curr Top Membr Transp Volume: 11 Page(s): 233 - 277
    01/01/1978 Authors: Compans RW; Kemp MC
  • Effects of filipin on the structure and biological activity of enveloped viruses.
    J Virol Volume: 24 Page(s): 883 - 892
    12/01/1977 Authors: Majuk Z; Bittman R; Landsberger FR; Compans RW
  • Structural proteins of Tacaribe and Tamiami virions.
    Virology Volume: 83 Page(s): 84 - 95
    11/01/1977 Authors: Card GP; Vezza AC; Bishop DH; Compans RW
  • Structural components of the arenavirus Pichinde.
    J Virol Volume: 23 Page(s): 776 - 786
    09/01/1977 Authors: Vezza AC; Gard GP; Compans RW; Bishop DH
  • The cellular site of sulfation of influenza viral glycoproteins.
    Virology Volume: 79 Page(s): 381 - 392
    06/15/1977 Authors: Nakamura K; Compans RW
  • Characterization of visna virus envelope neuraminic acid.
    J Virol Volume: 22 Page(s): 832 - 834
    06/01/1977 Authors: August MJ; Harter DH; Compans RW
  • Structural components of mouse mammary tumor virus. I. Polypeptides of the virion.
    Virology Volume: 76 Page(s): 751 - 766
    02/01/1977 Authors: Yagi MJ; Compans RW
  • Structural components of influenza C virions.
    J Virol Volume: 21 Page(s): 658 - 665
    02/01/1977 Authors: Compans RW; Bishop DH; Meier-Ewert H
  • Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.
    J Gen Virol Volume: 33 Page(s): 159 - 163
    10/01/1976 Authors: Palese P; Compans RW
  • Effect of membrane protein on lipid bilayer structure: a spin-label electron spin resonance study of vesicular stomatitis virus.
    Biochemistry Volume: 15 Page(s): 2356 - 2360
    06/01/1976 Authors: Landsberger FR; Compans RW
  • Observations on the membrane organization of standard and incomplete influenza grown in MDBK cells.
    Virology Volume: 71 Page(s): 389 - 394
    06/01/1976 Authors: Lenard J; Tsai DK; Compans RW; Landsberger FR
  • Permeability properties of the membrane of vesicular stomatitis virions.
    Biochim Biophys Acta Volume: 433 Page(s): 63 - 74
    04/16/1976 Authors: Bittman R; Majuk Z; Honig DS; Compans RW; Lenard J
  • Isolation and characterization of the nonglycosylated membrane protein and a nucleocapsid complex from the paramyxovirus SV5.
    Virology Volume: 67 Page(s): 365 - 374
    10/01/1975 Authors: McSharry JJ; Compans RW; Lackland H; Choppin PW
  • Sulfated components of enveloped viruses.
    J Virol Volume: 16 Page(s): 859 - 866
    10/01/1975 Authors: Pinter A; Compans RW
  • The organization of the proteins of vesicular stomatitis virions: labeling with pyridoxal phosphate.
    Virology Volume: 66 Page(s): 610 - 615
    08/01/1975 Authors: Eger R; Compans RW; Rifkin DB
  • Incorporation of sulfate into influenza virus glycoproteins.
    Virology Volume: 66 Page(s): 151 - 160
    07/01/1975 Authors: Compans RW; Pinter A
  • Polypeptide composition of incomplete influenza virus grown in MDBK cells.
    Virology Volume: 65 Page(s): 418 - 426
    06/01/1975 Authors: Lenard J; Compans RW
  • Time course of synthesis and assembly of influenza virus proteins.
    J Virol Volume: 14 Page(s): 1083 - 1091
    11/01/1974 Authors: Meier-Ewert H; Compans RW
  • Hemagglutination-inhibition: rapid assay for neuraminic acid-containing viruses.
    J Virol Volume: 14 Page(s): 1307 - 1309
    11/01/1974 Authors: Compans RW
  • Proteolytic cleavage of subunits of the nucleocapsid of the paramyxovirus simian virus 5.
    J Virol Volume: 14 Page(s): 1253 - 1261
    11/01/1974 Authors: Mountcastle WE; Compans RW; Lackland H; Choppin PW
  • Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.
    Virology Volume: 61 Page(s): 397 - 410
    10/01/1974 Authors: Palese P; Tobita K; Ueda M; Compans RW
  • Analysis of the in vitro product of an RNA-dependent RNA polymerase isolated from influenza virus-infected cells.
    J Virol Volume: 14 Page(s): 191 - 197
    08/01/1974 Authors: Caliguiri LA; Compans RW
  • The membrane structure of lipid-containing viruses.
    Biochim Biophys Acta Volume: 344 Page(s): 51 - 94
    04/08/1974 Authors: Lenard J; Compans RW
  • Assembly of lipid-containing viruses.
    J Supramol Struct Volume: 2 Page(s): 496 - 511
    01/01/1974 Authors: Compans RW; Meier-Ewert H; Palese P
  • Organization of the lipid phase in viral membranes. Effects of independent variation of the lipid and the protein composition.
    Biochemistry Volume: 12 Page(s): 4498 - 4502
    10/23/1973 Authors: Landsberger FR; Compans RW; Choppin PW; Lenard J
  • Distinct carbohydrate components of influenza virus glycoproteins in smooth and rough cytoplasmic membranes.
    Virology Volume: 55 Page(s): 541 - 545
    10/01/1973 Authors: Compans RW
  • The formation of poliovirus particles in association with the RNA replication complexes.
    J Gen Virol Volume: 21 Page(s): 99 - 108
    10/01/1973 Authors: Caliguiri LA; Compans RW
  • Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA.
    Virology Volume: 52 Page(s): 199 - 212
    03/01/1973 Authors: Lazarowitz SG; Compans RW; Choppin PW
  • Isolation and properties of an RNA polymerase from influenza virus-infected cells.
    J Virol Volume: 11 Page(s): 441 - 448
    03/01/1973 Authors: Compans RW; Caliguiri LA
  • ASSOCIATION OF INFLUENZA VIRAL MEMBRANE PROTEINS WITH CYTOPLASMIC MEMBRANES
    JOURNAL OF CELL BIOLOGY Volume: 59 Page(s): A62 - A62
    01/01/1973 Authors: COMPANS RW
  • Influenza virus proteins. II. Association with components of the cytoplasm.
    Virology Volume: 51 Page(s): 56 - 70
    01/01/1973 Authors: Compans RW
  • Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein.
    Virology Volume: 50 Page(s): 640 - 652
    12/01/1972 Authors: Scheid A; Caliguiri LA; Compans RW; Choppin PW
  • A specific labeling procedure for proteins on the outer surface of membranes.
    J Biol Chem Volume: 247 Page(s): 6432 - 6437
    10/25/1972 Authors: Rifkin DB; Compans RW; Reich E
  • Isolation and characterization of ribonucleoprotein substructures from Rous sarcoma virus.
    Virology Volume: 50 Page(s): 65 - 75
    10/01/1972 Authors: Quigley JP; Rifkin DB; Compans RW
  • Structure of the ribonucleoprotein of influenza virus.
    J Virol Volume: 10 Page(s): 795 - 800
    10/01/1972 Authors: Compans RW; Content J; Duesberg PH
  • The sense of the helix of paramyxovirus nucleocapsids.
    J Mol Biol Volume: 65 Page(s): 167 - 169
    03/14/1972 Authors: Compans RW; Mountcastle WE; Choppin PW
  • Structure of the lipid phase of Rauscher murine leukemia virus.
    J Supramol Struct Volume: 1 Page(s): 50 - 54
    01/01/1972 Authors: Landsberger FR; Compans RW; Paxton J; Lenard J
  • Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes.
    Virology Volume: 46 Page(s): 830 - 843
    12/01/1971 Authors: Lazarowitz SG; Compans RW; Choppin PW
  • Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions.
    J Virol Volume: 8 Page(s): 722 - 729
    11/01/1971 Authors: McSharry JJ; Compans RW; Choppin PW
  • Identification of the spike proteins of Rous sarcoma virus.
    Virology Volume: 46 Page(s): 485 - 489
    11/01/1971 Authors: Rifkin D; Compans RW
  • Spin-labeled electron spin resonance study of the lipid-containing membrane of influenza virus.
    Proc Natl Acad Sci U S A Volume: 68 Page(s): 2579 - 2583
    10/01/1971 Authors: Landsberger FR; Lenard J; Paxton J; Compans RW
  • Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities.
    J Gen Virol Volume: 11 Page(s): 53 - 58
    04/01/1971 Authors: Chen C; Compans RW; Choppin PW
  • Location of the glycoprotein in the membrane of Sindbis virus.
    Nat New Biol Volume: 229 Page(s): 114 - 116
    01/27/1971 Authors: Compans RW
  • ENVELOPE OF A PARAINFLUENZA VIRUS AND PLASMA MEMBRANE OF HOST CELL
    FEDERATION PROCEEDINGS Volume: 30 Page(s): 1044 - &
    01/01/1971 Authors: CHOPPIN PW; KLENK HD; COMPANS RW; SCHEID A; CALIGUIR LA; MOUNTCAS WE; CHEN C
  • Proteins and glycoproteins of paramyxoviruses: a comparison of simian virus 5, Newcastle disease virus, and Sendai virus.
    J Virol Volume: 7 Page(s): 47 - 52
    01/01/1971 Authors: Mountcastle WE; Compans RW; Choppin PW
  • SPIN LABEL ESR STUDIES ON LIPID CONTAINING MEMBRANE OF INFLUENZA VIRUS
    FEDERATION PROCEEDINGS Volume: 30 Page(s): 1281 - &
    01/01/1971 Authors: LANDSBER FR; LENARD J; PAXTON J; COMPANS RW
  • Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins.
    Virology Volume: 42 Page(s): 880 - 889
    12/01/1970 Authors: Compans RW; Klenk HD; Caliguiri LA; Choppin PW
  • An electron microscopic study of the presence or absence of neuraminic acid in enveloped viruses.
    Virology Volume: 42 Page(s): 1158 - 1162
    12/01/1970 Authors: Klenk HD; Compans RW; Choppin WP
  • Nucleocapsid protein subunits of simian virus 5, Newcastle disease virus, and Sendai virus.
    J Virol Volume: 6 Page(s): 677 - 684
    11/01/1970 Authors: Mountcastle WE; Compans RW; Caliguiri LA; Choppin PW
  • Structure and cytopathic effects of Nelson Bay virus.
    J Virol Volume: 6 Page(s): 100 - 106
    07/01/1970 Authors: Gard G; Compans RW
  • Phenotypic mixing of envelope proteins of the parainfluenza virus SV5 and vesicular stomatitis virus.
    J Virol Volume: 5 Page(s): 609 - 616
    05/01/1970 Authors: Choppin PW; Compans RW
  • An electron microscopic study of single-cycle infection of chick embryo fibroblasts by influenza virus.
    Virology Volume: 39 Page(s): 499 - 515
    11/01/1969 Authors: Compans RW; Dimmock NJ
  • Effect of antibody to neuraminidase on the maturation and hemagglutinating activity of an influenza A2 virus.
    J Virol Volume: 4 Page(s): 528 - 534
    10/01/1969 Authors: Compans RW; Dimmock NJ; Meier-Ewert H
  • The nucleic acid of the parainfluenza virus SV5.
    Virology Volume: 35 Page(s): 289 - 296
    06/01/1968 Authors: Compans RW; Choppin PW
  • ISOLATION AND PROPERTIES OF RNA FROM PARAINFLUENZA VIRUS SV5
    FEDERATION PROCEEDINGS Volume: 27 Page(s): 616 - &
    01/01/1968 Authors: COMPANS RW; CHOPPIN PW
  • The length of the helical nucleocapsid of Newcastle disease virus.
    Virology Volume: 33 Page(s): 344 - 346
    10/01/1967 Authors: Compans RW; Choppin PW
  • Studies on pneumonia virus of mice (PVM) in cell culture. II. Structure and morphogenesis of the virus particle.
    J Exp Med Volume: 126 Page(s): 267 - 276
    08/01/1967 Authors: Compans RW; Harter DH; Choppin PW
  • Isolation and properties of the helical nucleocapsid of the parainfluenza virus SV5.
    Proc Natl Acad Sci U S A Volume: 57 Page(s): 949 - 956
    04/01/1967 Authors: Compans RW; Choppin PW
  • An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5.
    Virology Volume: 30 Page(s): 411 - 426
    11/01/1966 Authors: Compans RW; Holmes KV; Dales S; Choppin PW
  • SIMIAN VIRUS 5 - AN ELECTRON MICROSCOPIC STUDY OF MODERATE AND VIRULENT VIRUS-CELL INTERACTIONS
    FEDERATION PROCEEDINGS Volume: 25 Page(s): 311 - &
    01/01/1966 Authors: COMPANS RW; HOLMES KV; DALES S; CHOPPIN PW
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements